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ABSTRACT
The overall purpose of the current thesis was to evaluate the influence of various
exercise strategies on Parkinson's disease (PD). While countless exercise interventions
have been investigated in PD, results have been weak and inconclusive at best. As such,
there are currently no scientifically-validated recommendations for an optimal exercise
intervention. The four studies comprising this thesis have attempted to address the
shortcomings of previous literature, namely, inconsistent use of outcome measures, lack
of PD symptomatic measures, varying lengths of exercise interventions, absence of a
non-exercise control group, continued assessment of participants after exercise has ended,
and verifying replicability of findings.
The first study was focused on identifying objective outcome measures that are
predictive or reflective of the classic symptoms associated with PD. Symptomatic
assessment was conducted using the Unified Parkinson's disease Rating Scale (UPDRS),
the current gold standard for assessment of PD symptom severity. Objective outcome
measures included the timed-up-and-go (TUG), grooved pegboard (GP), and
spatiotemporal aspects of self-paced gait (velocity, step length). Backward elimination
regression analysis demonstrated that the place phase of the GP was the most predictive
of UPDRS score. Interestingly, no objective outcome measures were strongly correlated
with change on the symptomatic subsets that they were believed to be theoretically
evaluating. The results point to the continued need to identify objective outcome
measures reflective of symptomatic assessment. Further, exercise rehabilitation trials
should combine outcome measures with symptomatic assessment to ensure that
improvements are reflective of symptomatic improvement.
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The second study compared the influence of four exercise interventions (in
contrast to a non-exercising control group) on the symptoms of PD. The exercise
interventions included aquatic exercise, aerobic training, strength training and sensory
attention focused exercise (PD SAFEX). Each participant exercised three times per week
for a twelve week period and the same trained evaluator (blinded to group assignment)
performed symptomatic assessment of all participants before exercise began (pre-test)
after exercise ended (post-test) and following a minimum six week non-exercise period
(washout). Results displayed that the strength training and PD SAFEX interventions had
the greatest symptomatic benefit from pre-test to post-test. The aerobic intervention had
no apparent change to symptom severity across all three testing periods. Overall, the
current study suggests that PD SAFEX and strength training are more beneficial for
individuals with PD than aerobic or aquatic exercise.
The third study attempted to determine the influence of increased focus on
sensory feedback by comparing two identical exercise interventions that differed only in
the presence (PD SAFEX) or absence (non-SAFE) of increased attention on sensory
(specifically proprioceptive) feedback. Symptomatic assessment was combined with
objective outcome measures that assessed upper limb motor control, functional gait and
spatiotemporal aspects of self-paced gait. Findings suggested that both exercise
interventions resulted in similar benefits on the objective outcome measures, including
upper limb motor control (assessed using the grooved pegboard), functional gait
(assessed using the timed-up-and-go) and velocity and step length of self-paced gait.
Interestingly, only the PD SAFEX intervention resulted in improved PD symptoms
assessed using the UPDRS and symptomatic improvement was maintained after a six
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week non-exercise period. Thus, the increased focus on sensory feedback present in the
PD SAFEX intervention appears to have an important additional influence on the
symptoms of PD.
The final study assessed whether improved PD symptoms following a sensory
attention focused exercise (PD SAFEX) intervention could be replicated across multiple
administrations and secondly, whether the effect could be replicated when administered
by minimally trained individuals in the community. The PD SAFEX intervention was
administered to four separate groups at the Movement Disorders Research and
Rehabilitation Centre (MDRC) and twice at an exercise facility in the community
(YMCA). Over the six administrations of the PD SAFEX intervention, similar
symptomatic improvements were realized by participants. Interestingly, the community
based intervention appeared to gain a greater symptomatic benefit than the PD SAFEX
intervention administered by leaders knowledgeable in movement disorders and the
underlying neurological deficits focused on in the PD SAFEX intervention. The
consistency of the results displayed that symptomatic improvement following the PD
SAFEX intervention was not due to chance but attributable to the exercise. The ability of
the community based intervention to effectively administer the PD SAFEX intervention
suggests that the feasibility of global distribution of the PD SAFEX intervention would be
a logical direction for future research.
The methodological improvements employed in the current thesis allowed for
detailed and thorough comparisons to be drawn between various exercise interventions. It
has been shown that strength training and PD SAFEX interventions have the greatest
symptomatic benefit for individuals with PD. Further, the beneficial effect of increased
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focus on sensory feedback and the simplicity of application of the PD SAFEX intervention
suggest that the PD SAFEX intervention should be further explored for its ability to be
globally implemented.
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CHAPTER 1

INTRODUCTION
Parkinson's disease and its Neuroanatomical Correlates
Parkinson's disease (PD) is one of the most prevalent movement disorders
(Johnson & Almeida, 2007) caused by a degeneration of dopamine producing neurons in
the basal ganglia (Wolters & Francot, 1998). The hallmark symptoms of PD include
tremor, rigidity, bradykinesia (a slowness of movement), akinesia (overall absence of
movement), and postural instability (Guttman, Kish, & Furukawa, 2003). Secondary
impairments in PD include disturbance of the spatiotemporal aspects of gait such as step
length and cadence (Morris, Iansek, Matyas, & Summers, 1994); cognitive impairments;
micrographia (small writing); decreased speech volume; sleep disorders; and mood
fluctuations (Guttman et al., 2003; Leung & Mok, 2005; Wolters & Francot, 1998).
Unfortunately, the symptoms of PD only become visibly apparent after an estimated 60%
of the available dopamine has been lost (Wolters & Francot, 1998) and neural pathways
through the basal ganglia have been severely impaired.
The basal ganglia refers to the caudate nucleus, putamen, globus pallidus (internal
and external), subthalamic nucleus, and substantia nigra (Nolte, 2002). In PD, there is a
pronounced degeneration of dopamine producing neurons in the substantia nigra, pars
compacta, leading to a loss of dopamine in the striatum (Wolters & Francot, 1998). The
loss of dopamine in the striatum affects two pathways through the basal ganglia to the
thalamus that facilitate cortical output.
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The direct pathway begins with input from the cortex to the striatum, which then
sends an inhibitory signal to the globus pallidus internal. The output from the globus
pallidus internal to the thalamus is subsequently decreased, however, as the role of the
globus pallidus internal is to inhibit the output of the thalamus, decreased globus pallidus
internal - thalamus input results in increased thalamus - cerebral cortex output. In PD, a
lack of dopamine in the striatum, inhibits the direct pathway leading to decreased
striatum output, increased globus pallidus output, and ultimately decreased thalamus
output. The decreased thalamus output leads to diminished cortical activity, and is likely
the root cause of characteristic symptoms of PD including bradykinesia and hypometria
(small movements) (Nolte, 2002).
An indirect pathway also passes through the basal ganglia to affect cortical
output. The striatum sends an inhibitory signal to the globus pallidus external, decreasing
output from the globus pallidus external to the subthalamic nucleus. The globus pallidus
external is also inhibitory, thus a decreased output from the globus pallidus external leads
to increased output from the subthalamic nucleus to the globus pallidus internal. The
subthalamic nucleus is excitatory, and it increases the output from the globus pallidus
internal to the thalamus. As the globus pallidus internal inhibits the thalamus, increased
output from the globus pallidus internal results in decreased output from the thalamus. In
PD, the lack of dopamine increases the activity of the indirect pathway, ultimately
leading to decreased thalamus output and diminished cortical activity (Nolte, 2002).
The end stage of both pathways is thalamus - cerebral cortex projections which
are excitatory. In PD, the thalamus is inhibited by disruption in both pathways causing
diminished cortical output which could be the underlying cause of the small, slow
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movements observed in PD (Nolte, 2002; Wolters & Francot, 1998). As such, therapeutic
interventions have been aimed at identifying chemical messengers or neurotransmitters
that improve transmission along these pathways to restore proper thalamus - cerebral
cortex output.
The most common treatment for PD has revolved around pharmacotherapy to aid
the disrupted dopamine system in the basal ganglia. The main medications used in the
management of PD are levodopa (L-dopa), dopamine agonists, and monoamine oxidase
(MAO) inhibitors. L-dopa is the most common medication and is a dopamine precursor
which is metabolized in the periphery by dopa-decarboxylase (Leung & Mok, 2005).
Dopamine agonists are used to stimulate dopamine receptors which increase the
responsiveness of the neurons in the basal ganglia to the available dopamine. MAO
inhibitors are used to reduce dopamine metabolism in the brain, thus maintaining
dopamine levels (Guttman et al., 2003). The goal of utilizing medication to manage PD is
to prescribe the smallest dosage that allows the patient to continue doing the activities
that are important to them (Guttman et al., 2003).
Small dosages are prescribed, especially in the early stages of PD as a number of
motor (dyskinesia) and non-motor (nausea, hallucinations, sleep disorders) side effects
can result from extended pharmacotherapy. The motor side effects generally begin with a
wearing off of L-dopa medication, as the motor symptoms become more pronounced near
the end of the medication cycle before the next dosage is administered. To combat
wearing off of L-dopa, additional medications may be administered or L-dopa dosage
may be increased. As pharmacotherapy continues, dyskinesias (involuntary, jerky, dancelike movements of the head and arms) may become present (Guttman et al., 2003; Leung
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& Mok, 2005). While the medications are beneficial in the short term, none of these
therapies have proven to be neuroprotective or to delay the progression of Parkinson's
disease (Guttman et al., 2003). Thus, once a patient begins using medication to treat PD,
they will gradually increase their dose and reliance on medication to function optimally.
Since, reliance on medication alone may not be the optimal strategy for
management of PD, non-pharmacological treatments are of increasing importance and
have been suggested to lead to lower therapeutic levels of dopaminergic medications
needed, thereby improving the long-term prognosis (Johnson & Almeida, 2007). While
effective management of PD will likely always involve some level of medication, the
longer a patient can wait before beginning medication and the smaller the dosage needed
to maintain optimum functioning, the better for the patient.
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Exercise and the PD brain
Physical exercise may not be an obvious choice of adjunct therapy for a
neurological condition; however, animal models have demonstrated that exercise has the
potential to positively affect brain plasticity and dopamine production. Following
exercise, rats have been shown to increase serum calcium levels, which are transported to
the brain, leading to an increase in dopamine production through a calmodulin-dependent
system (Sutoo & Akiyama, 2003). Other animal models have evaluated the notion that
exercise may potentiate the intrinsic plasticity of the brain by increasing expression of
neurotrophic factors such as Brain Derived Neurotrophic Factor (BDNF). BDNF
increases the activity of Synapsin I, which aids in the proper release of neurotransmitters
at the synapse and in the development of new synapses (i.e. new pathways through the
central nervous system) (Vaynman & Gomez-Pinilla, 2005). BDNF specifically, has been
shown to be up-regulated by exercise and thus, exercise may benefit those with PD by
increasing the activity of BDNF and Synapsin I which may aid in proper transmission
across dopamine depleted synapses in the basal ganglia, or through the development of
new neural pathways to aid or avoid the damaged basal ganglia. These animal models
provide biological plausibility for the use of exercise as a specific treatment for PD.
Parkinson's disease specific animal models, however, have been contradictory
regarding the benefit of exercise on PD, with the main difference being the stage of
disease progression. A study of early exercise intervention by Tillerson et al. using both
rat and mice models of PD found that exercise was beneficial. Specifically, significant
sparing of striatal dopamine, its metabolites, tyrosine hydroxylase, vesicular monoamine
transporter, and dopamine transporter levels were found in animals that ran on a treadmill
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compared to PD induced sedentary animals (Tillerson, Caudle, Reveron, & Miller, 2003).
It is important to note that the animals in this study began exercising twelve hours after
being induced with PD, and were considered mild severity PD. Another study by AlJarrah et al. used mice that had been induced with chronic PD. This was done by injecting
l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine (MPTP) ten times over a period of five
weeks; which is an excessive dosage as normally MPTP is only injected once in order to
induce PD in mice. The chronic PD mice were able to gain all of the cardiorespiratory
benefits (decreased heart rate, increased VO2, etc) of exercise but had no change in
striatal dopamine, or its metabolites (Al-Jarrah et al., 2007). These studies raise the idea
that there may be a certain period of neural deterioration in PD beyond which exercise
will no longer affect brain plasticity or dopamine production. Further, the animal models
are intriguing starting points as they provide information from invasive measurement but
they do not necessarily reflect the effect of exercise on the human brain.
Animal models suggest biological plausibility of the potential effect of exercise
on the PD brain. Exercise may help reduce reliance on current pharmacotherapy (and
avoid the associated side effects) through improved functioning of the direct and indirect
pathways through the basal ganglia affecting thalamus - cortical output. Thus,
investigating the effect of exercise as an adjunct therapy for PD is warranted.
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The Need to Identify Appropriate Outcome Measures for PD Interventions
The use of exercise as an alternative therapy in the management of PD has a fairly
extensive history. However, no acceptable, scientifically validated guidelines for exercise
are currently available (de Goede, Keus, Kwakkel, & Wagenaar, 2001; Deane et al.,
2002). One of the reasons for the lack of conclusion regarding exercise in PD has been
the inconsistent use of appropriate outcome measures and a lack of symptomatic
measures relevant to PD.
The most important aspect of any PD rehabilitation strategy is the improvement of
PD symptoms. While elements such as gait and mobility are impaired in PD and should
be a focus of exercise rehabilitation, a literature review determined that mobility can be
more easily influenced by physical therapy than neurological symptoms can (de Goede et
al., 2001). This brings into question previous exercise rehabilitation research that has
only used gait and mobility outcome measures and not included a PD symptomatic
measure (Caglar, Gurses, Mutluay, & Kiziltan, 2005; Cakit, Saracoglu, Gene, Erdem, &
Inan, 2007; del Olmo, Arias, Furio, Pozo, & Cudeiro, 2006; del Olmo & Cudeiro, 2005;
Li et al, 2007; Lokk, 2000; Sunvisson, Lokk, Ericson, Winblad, & Ekman, 1997; Thaut
et al., 1996; Viliani et al., 1999). Without combined improvement in both mobility and
PD specific clinical measures it cannot be determined whether the exercise program was
beneficial for the specific neurological deficits in PD or simply beneficial in a general
cardiorespiratory and musculoskeletal sense. Essentially, clinical measures of PD
symptoms are a critical component to PD exercise rehabilitation research to determine if
the exercise is in fact beneficial in a disease specific manner.
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The Unified Parkinson's Disease Rating Scale (UPDRS) (Fahn, 1987), may be the
best option to address the identified lack of PD symptomatic measures in exercise
rehabilitation trials. The UPDRS is the current gold standard for clinical assessment of
Parkinson's symptoms and is used to detect symptomatic changes when approving new
medications. PD symptoms are assessed individually using a five point scale with zero
representing no symptoms present and four representing the most severe symptoms. The
UPDRS is split into three major sections to assess mentation, behavior and mood,
activities of daily living, and motor symptoms. Consistent use of a standardized measure
of PD symptoms, such as the UPDRS, would allow for effective comparison between
exercise interventions.
Additionally, a lack of symptomatic measure is concerning as it has been
increasingly recognized that improvement in a specific impairment such as step length,
which is easily altered and measured, may have little benefit for the patient in their life
(Deane et al., 2002). Further, the most consistently used measures in PD literature have
been spatiotemporal aspects of gait, primarily step length, cadence and velocity.
Although commonly utilized rarely do two studies measure these variables in the same
manner. Self-paced gait has been measured over a number of distances including 4 m
(Thaut et al., 1996), 10 m (Miyai et al., 2000; Miyai et al., 2002; Nieuwboer et al., 2007),
20 m (Caglar et al., 2005) and 30 m (del Olmo et al., 2006; del Olmo & Cudeiro, 2005).
Some researchers have used a treadmill to determine comfortable walking speed (Ellis et
al., 2005), which limits the applicability to a real-world setting. Of note, other studies
where the exercise was hikes in the mountains, with a focus on increasing mobility, no
measure of gait was used (Lokk, 2000; Sunvisson et al., 1997). Some researchers have
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attempted to analyze gait under various conditions including walking over uneven
surfaces such as up a ramp and down a step (Thaut et al., 1996) or around obstacles
(Brichetto, Pelosin, Marchese, & Abbruzzese, 2006), while performing secondary tasks
such as turning the head (Cakit et al., 2007), or various reproduction tasks such as
matching pace with a metronome (del Olmo & Cudeiro, 2005). The different conditions
used to measure spatiotemporal aspects of gait make it difficult to compare changes and
the changes may not be reflective of symptomatic improvement in PD.
One interesting and potentially beneficial measure of gait may be to analyze
changes in variability as PD results in variable movements especially surrounding aspects
of gait such as step length (Hausdorff, Cudkowicz, Firtion, Wei, & Goldberger, 1998).
Conceivably, if an exercise intervention has improved PD symptoms, then step to step
variability would be reduced. Some research has found a decrease in gait variability such
that following exercise individuals with PD were no longer significantly different than
healthy height matched controls (del Olmo et al., 2006; del Olmo & Cudeiro, 2005).
Improvements in gait variability, indicated by a stable and consistent gait pattern, may be
more beneficial measures as they may represent improved neurological functioning
relating to gait sequences including movement initiation, amplitude and dynamic balance
control.
Goal-directed mobility tasks have also been used in the literature with the most
prominent test being the Timed-up-and-go (TUG). Tasks such as the TUG are considered
functional tasks that mirror everyday activities. The TUG involves rising from a chair,
walking 3 meters, returning to the chair and sitting down, which represent specific
deficits in PD such as sit-to-stand, movement initiation and dynamic balance while
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turning. Further, goal-directed tasks may require a conscious control of movement and
are potentially a superior measure of changes to neural function than self-paced gait.
Other, non-standardized functional tests that have been used include transfers and
sit-to-stand movements (Viliani et al., 1999), a posturo-locomotor-manual task where an
object is picked up and carried a distance (Sunvisson et al., 1997), and walking around a
chair (Caglar et al., 2005). Similarly, numerous mobility measures have been attempted
to assess functional changes such as the functional reach test (Li et al., 2007) and the
Berg Balance Test (Cakit et al., 2007). The majority of these measures have not been
used consistently and further complicate comparison between studies.
Other deficits in PD such as bradykinesia and fine motor control have been even
less consistently measured. Bradykinesia is measured as a portion of the overall UPDRS,
however a specific bradykinesia outcome is not provided. The UPDRS motor section
does have the ability to be broken down into its components to look at specific
impairments. Marchese et al. separated midline bradykinesia (items 18, 19, 27, 30, and
31) and limb bradykinesia (items 23-26) in an attempt to measure bradykinesia more
effectively (Marchese, Diverio, Zucchi, Lentino, & Abbruzzese, 2000). Others have used
timed movement sequences as a measure of bradykinesia (Sunvisson et al., 1997; Tamir,
Dickstein, & Huberman, 2007). However, the majority of researchers do not use separate
measures to specifically examine bradykinesia, which is surprising considering it is one
of the cardinal symptoms of PD.
Another aspect of PD that is not consistently measured is fine visuomotor control.
Changes in fine motor control are not often assessed in PD literature as the focus is
primarily mobility (Johnson & Almeida, 2007). However, fine motor control is integral in
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the maintenance of independence as it is involved in tasks such as tying shoes, doing up
buttons, and cutting food. Fine motor control is an important measure in PD as
individuals with PD have been shown to have a dysfunction in sequential movements
such as reaching for a glass and taking a drink (Bennett, Marchetti, Iovine, & Castiello,
1995). The limited studies that have measured fine motor control have used the Purdue
Pegboard (Craig, Svircev, Haber, & Juncos, 2006; Reuter, Engelhardt, Stecker, & Baas,
1999) or a Nine Hole Peg Board (Caglar et al., 2005). Outcome measures assessing fine
motor control would be beneficial as they are another identified deficit in PD and
assessing the effect exercise has on a wide range of PD deficits allows a more complete
conclusion to be reached.
The inconsistent use and absence of symptomatic outcome measures in PD
exercise rehabilitation literature makes comparison between interventions difficult and
points to the need for standardized measures to be used across all exercise studies in PD.
To address this shortcoming one important aim of the current thesis is to evaluate which
objective measures represent symptomatic assessment with the UPDRS.
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Parkinson's disease and Exercise Rehabilitation
Previous exercise rehabilitation research has been inconclusive, and thus unable
to provide recommendations for exercise and PD (de Goede et al., 2001; Deane et al.,
2002), but this has not been through a lack of trying. Exercise interventions that have
been evaluated can be generally grouped into aerobic, strength/regular physical therapy
practices, and sensory techniques.
Aerobic interventions have been aimed at increasing mobility and aerobic
capacity and usually used a form of walking as training. Walking inside and outside
(Ashburn et al., 2007), mountain hiking (Lokk, 2000; Sunvisson et al., 1997), treadmill
training (Bergen et al., 2002; Cakit et al., 2007; Herman, Giladi, Gruendlinger, &
Hausdorff, 2007; Pohl, Rockstroh, Ruckriem, Mrass, & Mehrholz, 2003), body weight
supported treadmill training (Miyai et al., 2000; Miyai et al., 2002) and cycle ergometry
(Bergen et al., 2002; Burini et al., 2006) have all been attempted with PD populations.
While aerobic interventions are likely beneficial for cardiorespiratory fitness, their
effect on PD symptoms is less clear. For example, Miyai et al. used body-weight
supported treadmill training (BWSTT) in two studies to determine its effects relative to
regular physical therapy. The identical interventions found conflicting results in regard to
PD symptoms. The first study found a significantly greater improvement on the UPDRS,
specifically the ADL and motor sections, in BWSTT over regular physical therapy
(Miyai et al., 2000). Conversely, the second study found no significant differences in the
UPDRS following either BWSTT or physical therapy (Miyai et al, 2002). These
conflicting results, regarding aerobic training using the same intervention, point to the
need for more work to be done in the area of aerobic training and PD. Further, it is worth

12

noting that aerobic interventions involving walking have generally resulted in
improvements in spatiotemporal aspects of gait, specifically velocity and step length,
while the effect on clinical PD symptoms has not been measured consistently and is less
clear.
The second grouping of exercise interventions falls under strength training and
physical therapy practices. The aim of these interventions is generally to increase
mobility, strength, range of motion and balance to assist with activities of daily living.
These interventions have been done under numerous conditions including group or
individual settings at the home, gym, and pool. Again, conflicting results have been
found in relation to neurological symptoms, measured using the UPDRS, as some studies
found positive results (Reuter et al., 1999), some found no significant improvement
(Brichetto et al., 2006; Ellis et al, 2005) and others did not measure PD symptoms
(Caglar et al., 2005; Viliani et al, 1999). Conflicting results concerning the effect of a
strengthening program are troubling considering the majority of these interventions were
based on current physical therapy practices for the treatment of PD.
Whole body strength training interventions have been studied even less frequently
than physical therapy interventions. Two studies have been identified that utilized
resistance exercises similar to a whole body program an individual might undergo at a
fitness facility (Hass, Collins, & Juncos, 2007; Hirsch, Toole, Maitland, & Rider, 2003).
One study measured PD symptoms with the UPDRS but found no significant difference
after training (Hass et al., 2007). The second study found improved muscle strength and
balance tests but had no PD symptomatic measure (Hirsch et al., 2003). Currently, there
is an insufficient amount of research in the area of strength training to draw any
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conclusions as to their efficacy; however, well designed research utilizing clinical
measures of PD symptoms may be able to determine if strength training is an effective
strategy for individuals with PD.
The third exercise rehabilitation strategy, which is also one of the most promising
avenues of neurological rehabilitation research involves the use of sensory enhancement
to cue movement (Johnson & Almeida, 2007). The use of external cues to overcome
deficits in gait has been well documented and it has been shown that auditory and visual
cues can improve the disturbed gait present in PD (Lewis, Byblow, & Walt, 2000;
Morris, Iansek, Matyas, & Summers, 1996; Rubinstein, Giladi, & Hausdorff, 2002). For
example, if transverse lines are placed on the ground at distances equal to height matched
controls, individuals with PD are able to improve their step length, cadence and velocity
(Morris et al., 1996). Auditory cues have also been used in the form of a metronome
paced faster than a patient's comfortable cadence and shown improvements in cadence,
velocity and stride length among individuals with PD (Rubinstein et al., 2002). The
external cues have been suggested to assist individuals with PD to overcome basal
ganglia deficits. One hypothesized role of the basal ganglia is the selection of the
appropriate motor set to complete a movement (Rubinstein et al., 2002). Thus, visual
cues have been proposed to focus a participant's attention on gait and invoke a cortical
control of movement, bypassing the dysfunctional basal ganglia and allowing for the
proper motor set to be selected and carried out (Morris et al., 1996). A second
hypothesized role of the basal ganglia is the internal regulation of submovements of a
motor set to ensure the proper activation and deactivation of the appropriate areas of the
supplementary motor area to carry out smooth movement during sequential movements
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such as gait (Rubinstein et al., 2002). Perhaps, auditory cues are beneficial as they
provide external cues that replace the dysfunctional signals from the basal ganglia. The
exact mechanism behind the benefits observed through external cueing is less important
than the fact that cues have shown visible improvements in PD gait.
Numerous studies have attempted to apply the concepts of external cueing to
exercise to determine if the short-term benefits observed in the laboratory will enhance
the benefits of physical therapy (Brichetto et al., 2006; Marchese et al., 2000; Nieuwboer
et al., 2007) or mobility training (del Olmo et al., 2006; del Olmo & Cudeiro, 2005;
Thaut et al., 1996). Similar to more traditional forms of exercise, results from cueing
strategies have been mixed. However, there is promise as demonstrated by Marchese et
al. who followed two groups that completed identical exercise interventions except for
the presence or absence of sensory cues. While they found both groups had a significant
improvement in their UPDRS scores, of greater interest was that the cued group
maintained their benefits six weeks following the end of the exercise program, while the
beneficial effects had disappeared in the non-cued group (Marchese et al., 2000). These
findings were suggested to display that sensory cueing invokes neurological changes that
last longer than musculoskeletal changes resulting from traditional forms of exercise.
Further benefits of mobility training using cues have been found; however, the
studies did not use a clinical symptom measure such as the UPDRS as an outcome
measure. These interventions did use other measures that suggested the interventions
were improving neurological function. One group analyzed movement variability and
found that following four weeks of exercise paced by a metronome individuals with PD
had less variable movement such that they were no longer different than healthy controls
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(del Olmo et al., 2006; del Olmo & Cudeiro, 2005). Thaut et al. used EMG to examine
muscle activation and found that three weeks of gait exercises paced using rhythmic
auditory stimulation (cueing beats infused into music) resulted in a change towards a
more normal muscle activation pattern during gait (Thaut et al., 1996). Other sensory
techniques that have been explored further complicate the search for an answer. Mental
imagery resulted in an improvement in UPDRS (Tamir et al., 2007), Qigong resulted in
no improvement in UPDRS (Burini et al., 2006), and tai chi did not measure UPDRS (Li
et al., 2007). Although the measures used have been inconsistent, sensory cueing
techniques have generally had greater positive benefits than traditional exercise and
therefore warrant further investigation.
The use of external cues in exercise rehabilitation has been promising; however, it
may not be the optimal approach. While lines taped on the ground have been able to
increase step length in individuals with PD, this approach is not transferable as lines are
not taped on sidewalks or mall floors. Similarly, auditory cues may be transported
through portable auditory devices but may require attentional demands that place a
person at increased risk. If a person must focus on the beats of a metronome coming
through headphones while walking through a busy shopping mall they may actually have
increased difficulty with the multiple demands of listening to the beat while maneuvering
around obstacles (people, benches, signs, etc.). Thus, other more permanent techniques
with potential to improve functioning among individuals with PD need to be investigated
in rehabilitation settings.
One area that has recently received considerable research interest in terms of its
role in PD is the influence of the basal ganglia on sensorimotor integration, especially
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during motion. It has been seen that individuals with PD exhibit an abnormal central
processing of proprioceptive input which provides an inaccurate internal representation of
the body's motion (Jacobs & Horak, 2006). Sensorimotor integration has generally been
investigated under conditions restricting or allowing vision. For example, Almeida et al.
examined individuals with PD after withdrawing dopaminergic medication and again at
peak dose of dopaminergic medication under four conditions which altered the feedback
available. The task had participants in complete darkness, then a target LED was
illuminated, turned off and participants were instructed to move to that target. One
condition of interest, illuminated the target LED for three seconds, and then had
participants walk towards the target in complete darkness; therefore, only proprioceptive
feedback was available. Interestingly, on medication individuals with PD had
significantly less error (2D radial error from target once participant stopped walking) then
individuals off their medication. As the optimally functioning basal ganglia (on
medication) resulted in less error than the poorly functioning basal ganglia (off
medication) it was suggested that the basal ganglia is a critical component involved in
integrating proprioceptive feedback during movement (Almeida et al., 2005).
Applying the identified proprioceptive integration deficit to a rehabilitation
setting has never been attempted in Parkinson's disease. Thus, an important aim of the
current thesis was to determine if an exercise program focused on the sensorimotor
deficit is beneficial for individuals with PD. Further, this exercise program [Sensory
Attention Focused Exercise (PD SAFEX)], was compared to traditional forms of exercise
including aquatic, aerobic and strength/resistance training and a non-exercise control
group. The variety of exercise rehabilitation trials previously evaluated used different
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outcome measures and did not allow for adequate comparisons to be made between the
interventions. Therefore, reaching an ultimate conclusion on the efficacy of exercise as an
alternative treatment to PD is not currently feasible. Another main focus of the current
thesis was to compare various exercise interventions using identical outcome measures to
attempt to answer the question of which exercise program is the most beneficial for
individuals with PD.
As should apply to any potentially beneficial therapeutic intervention, ensuring
that the effectiveness can be replicable is important. As such, an important aspect of this
thesis was to compare symptomatic changes resulting from a sensory attention focused
exercise (PD SAFEX) program that was administered numerous times. Additionally, the
effectiveness of the PD SAFEX program was evaluated to determine the ability of the
program to be run in community based situations by individuals with minimal training in
movement disorders.
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Thesis Objectives
The main objective of the current thesis was to identify the optimal exercise
strategy for individuals with Parkinson's disease. To address this objective the following
four chapters will investigate important questions and attempt to improve upon
shortcomings of previous work. The first chapter evaluates the ability of objective
outcome measures to reflect changes identified through clinical evaluation with the
Unified Parkinson's Disease Rating Scale. The purpose was to determine which outcome
measures provide the most information regarding specific improvements in PD symptoms
to identify the most disease relevant measures for use in exercise rehabilitation trials.
The second chapter compares various exercise strategies to determine which
exercise strategy is the most effective for individuals with PD. A number of shortfalls in
previous research were controlled for including, similar lengths of exercise intervention,
identical symptomatic outcome measures, and comparison with a non-exercise control
group to allow for adequate comparison between exercise interventions.
Chapters three and four focus on a specially designed exercise program, Sensory
Attention Focused Exercise (PD SAFEX) that required participants to rely on
proprioceptive feedback to properly complete each exercise. Chapter three compared the
PD SAFEX program to a similar exercise program that did not focus on proprioceptive
feedback. Chapter four addressed the replicability of the PD SAFEX program to determine
whether the program provided consistent results. Additionally, the ability of the PD
SAFEX program to be administered by individuals in the community with minimal
training was evaluated.
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Finally, a concluding chapter provides a summary of the findings and provides
suggestions for the optimal exercise strategy for individuals with PD.
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CHAPTER 2

THE RELATIONSHIP BETWEEN OBJECTIVE OUTCOME MEASURES AND
SYMPTOMATIC ASSESSMENT OF PARKINSON'S DISEASE
ABSTRACT
Limited work has been conducted to identify specific and objective outcome
measures that reflect symptomatic change in Parkinson's disease (PD). The current study
aimed to determine which measures were best able to predict PD symptoms, measured
using the Unified Parkinson's Disease Rating Scale (UPDRS) and also which measures
were reflective of symptomatic changes. One hundred and eleven participants were
assessed as part of a large exercise rehabilitation trial in PD at the Movement Disorders
Research and Rehabilitation Centre, Wilfrid Laurier University. Outcome measures
included the Unified Parkinson's Disease Rating Scale (UPDRS), Timed-Up-and-Go
(TUG), place and remove phase of the Grooved Pegboard (GP) on both the affected and
non-affected sides, and spatiotemporal aspects of self-paced gait. Participants were
assessed before commencing exercise (pre-test) and immediately following the end of the
twelve week program (post-test). The first analysis was a backward elimination linear
regression using all outcome measures to predict overall UPDRS. The place phase of the
GP on the non-affected side was found to be the most predictive of UPDRS score,
accounting for 26.9% of the variability in UPDRS score. The second analysis was to
determine the ability of secondary outcome measures to reflect symptomatic changes
identified through the UPDRS. Correlation analysis was conducted to determine the
relationship between the TUG and GP and specific subsets of the UPDRS that were
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chosen to represent the areas assessed by the TUG and GP. Percent change [(pre-test post-test)/pre-test x 100%] was used to standardize the measures, and control for pre-test
disease severity. No significant relationships between the UPDRS subsets and their
corresponding outcome measures were identified. As no objective measures were seen to
have a relationship with the UPDRS symptom severity scale, the results suggest that both
measures should be inspected to ensure that improvements are reflective of symptomatic
improvement.
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INTRODUCTION
Parkinson's disease (PD) is a debilitating movement disorder with symptoms that
can often restrict movement, be accompanied with pain, and limit independence.
Symptoms such as tremor, rigidity, and poor mobility are typically treated with dopamine
replacement agents, although long-term administration of dopamine can lead to
debilitating side-effects such as dyskinesia (involuntary movements of the head and
arms), hallucinations and sleep disorders (Leung & Mok, 2005). Thus, the search for
effective alternative therapies to complement and decrease reliance on medication is
important for the PD community.
Various exercise strategies have been investigated for their benefit for individuals
with PD; however, no consensus on recommendations can currently be made (de Goede,
Keus, Kwakkel, & Wagenaar, 2001; Deane et al., 2002). One of the problems plaguing
previous research is the inconsistent use of symptom specific outcome measures. For
example, a large study into the effects of sensory cued exercises (n=153) by Nieuwboer
et al. had participants complete mobility exercises with a physiotherapist. The outcome
measures were a posture and gait score, spatiotemporal aspects of self-paced gait (step
length, velocity, cadence), single and double leg stance tests, the timed-up-and-go, and a
number of questionnaires (Nieuwboer et al., 2007). While the exercise intervention did
reveal positive effects on the posture and gait score, spatiotemporal aspects of gait, and
stance tests, it is unclear whether these benefits are symptom specific or general
musculoskeletal improvements. It has also been suggested that physical therapy can
influence mobility more easily than neurological symptoms (de Goede et al., 2001).
Further, specific impairments (step length, velocity) can be easily altered and measured
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but may have little benefit for the patient in their day to day life (Deane et al., 2002).
Thus, while Nieuwboer et al. (2007) were able to influence mobility, it is unclear what
effect the exercise had on global PD symptoms.
Exercise interventions in PD should be aimed at improving neurological function
and ultimately improved PD symptoms. Thus, the outcome measures used should be
symptom specific and reflect clinical symptomatic measures. In a strength training
intervention, it was found that individuals with PD improved muscle strength following
the training (Hirsch, Toole, Maitland, & Rider, 2003). However, the question remains are
these benefits symptom specific or was the increased muscle strength a benefit that any
individual would receive from strength training. With no PD symptomatic measure, the
relative impact of the exercise on PD cannot be determined.
Clinically, PD symptoms are measured using the Unified Parkinson's Disease
Rating Scale (UPDRS) (Fahn, 1987). The UPDRS is the current gold standard and has a
trained clinician rate each PD symptom using a scale from zero to four (zero represents
no symptoms present and four represents the most severe symptoms). It is also the most
critical measure used to identify symptom improvement when approving new drug
treatments for PD. The UPDRS measures disease severity and provides an approximation
of the neurological functioning of the basal ganglia as more severe PD symptoms result
from more severely impaired basal ganglia. Thus, the UPDRS is currently the best
available clinical measure for determining the symptom specific effect of exercise.
However, using the UPDRS is not feasible for all researchers or individuals in the
community who may be administering exercise programs to individuals with PD. For
instance, a trained UPDRS evaluator is not always accessible to researchers and tracking
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the progress of an individual with PD in a non-research based environment can be
difficult for individuals without specialized training such as an exercise leader.
Additionally, the UPDRS for all its benefits is still a subjective rating by a clinician.
Thus, the main objective of the current study was to determine the most useful objective
outcome measures for use in research and community environments that are
representative of symptom changes identifiable with the UPDRS. Furthermore, while it
might be ideal to evaluate participants on a wide range of outcome measures including
brain scans, the current study attempted to gain a holistic assessment of participants under
realistic testing conditions (approximately one hour).
Identifying measures that are most representative of PD symptoms is an important
undertaking, as limited work has been conducted in this area. The only research that has
focused on this type of question attempted to establish whether level of disease severity
might predict the potential benefit received from physiotherapy (Nieuwboer, De Weerdt,
Dom, & Bogaerts, 2002). However, the dependent variable was a Parkinson's activity
scale developed to focus on functional abilities that, might be altered through
physiotherapy, and UPDRS score at baseline was one of the predictor variables
(Nieuwboer et al., 2002). The results indicated that those with a lesser degree of severity
were more likely to benefit from physiotherapy interventions (when compared to more
severe individuals with PD). Another interesting study attempted to correlate specific PD
symptoms with nigrostriatal dopaminergic deficit, however, a modified Columbia scale
was used to assess symptoms which, although similar to the UPDRS is less commonly
used in PD research (Vingerhoets, Schulzer, Calne, & Snow, 1997). Thus, the current
study was unique as it attempted to not only determine which outcome measures are most
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predictive of disease severity as reflected by UPDRS score but more importantly, tested
participants before and after exercise to determine which objective outcome measures
might be useful indicators of symptomatic changes.

METHODS
Participants
As part of a large research project into the effect of exercise on PD at the
Movement Disorders Research and Rehabilitation Centre (MDRC) at Wilfrid Laurier
University, one hundred and eleven participants (F=42, M=69, age=67.1, SD=9.1) with
idiopathic PD were utilized in the current study. Testing took place from September 2006
to December 2007, and represented four rounds of exercise (fall 2006, winter 2007,
summer 2007, and fall 2007) at four sites across southern Ontario (including the MDRC,
and three YMCA's in Kitchener, Cambridge, and Oakville, Ontario). A single participant
could have participated in all four rounds of exercise, thus, to control for the potential
effect of multiple administrations of exercise and ensure independency of observations,
the 111 participants included in the current study were involved in their first round of
exercise (or were part of a non-exercise control group).
Multiple exercise strategies including aerobic training, strength training, aquatic
exercise, and sensory feedback based exercise were administered. Additionally,
participants unable to commit to the requirements of an exercise program were enlisted as
part of a non-exercise waitlist control group. Each exercise program lasted between 10-12
weeks, or 30-36 classes depending on when the program was completed (due to seasonal
holidays), followed by a six week period with no exercise. Participants were required to
exercise three times per week regardless of the exercise program. Additionally, all
participants, including non-exercise control participants, were instructed to maintain their
current medication schedule and regular physical activity for twelve weeks. Thus, the
only addition to a participant's regular schedule was the exercise intervention being
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investigated. Since the focus of the current study was to find outcome measures that
would reflect PD symptoms, the exercise groups were collapsed (for more detail on the
specific exercise strategies investigated please see Chapter 3). This research was
approved by the research ethics board at Wilfrid Laurier University and all subjects
signed informed consent forms before commencement of the study.

Clinical Symptom Assessment
The Unified Parkinson's Disease Rating Scale motor section (UPDRS) (Fahn,
1987) was the primary outcome measure, as it provided an overall assessment of the
motor symptoms of PD. A single certified evaluator (blinded to group assignment)
performed all UPDRS evaluations while participants' were at their peak dosage of antiparkinsonian medication. The UPDRS motor section is composed of fourteen items.
Some of these items are repeated on each upper or lower limb to reflect symptoms that
may be present in each appendage. Each item (or symptom) was rated on a scale ranging
from zero to four, where zero represented no identifiable symptoms present and four
represented the most severe symptoms; as such, the highest severity score possible was
108. The UPDRS was used as the dependent variable in the regression analysis, while the
objective outcome measures (timed-up-and-go, self-paced gait, grooved pegboard) were
used as predictors. Additionally, subsets of the UPDRS were calculated to determine if
changes in objective outcome measures were reflective of the specific symptomatic
changes they entailed. The specific UPDRS items used to calculate each subset are
explained in more detail below.
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Functional Gait
The Timed-Up-And-Go (TUG) was used to measure gait during a functional task,
as it required a sequence of movements including sit to stand, initiation of gait, and
dynamic balance control while turning. Each trial began with the participant in a seated
position in a standard office chair with armrests (All Seating Corporation, Model
No.3307). Participants were instructed to stand up, walk to a target three meters away,
turn around and return to a seated position in the chair as quickly as possible. Timing
began upon movement initiation (participant's back breaking contact with the chair) and
ended when the participant made contact with the chair in a seated position. The TUG
was completed twice and an average of the overall time for completion of the two trials
was used in statistical analysis.
A posture and gait (PG) score was calculated as a subset of the UPDRS to
examine its relationship with the TUG. The subset included items 27 (arising from a
chair), 28 (Posture), 29 (Gait), 30 (Postural Stability), and 31 (Body Bradykinesia). These
specific items were chosen as they have been suggested to be the clinical indicators of
posture and gait impairment according to the UPDRS (Sage & Almeida, In Press).

Upper Limb Motor Control and Bradykinesia
Upper limb motor control was assessed using the Grooved Pegboard (GP)
(Lafayette Instruments # 32035). The typical administration of the GP involves placing
25 pegs into key shaped slots as quickly as possible. However, a new administration of
the GP, which is more applicable to the aims of the current study, was used and involved
both the standard place phase and a remove phase where the 25 pegs were subsequently
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removed from the slots and placed in a large receptacle (Bryden & Roy, 2005). The two
phases measured different movement characteristics as the place phase tested fine
visuomotor control while the remove phase was more a test of movement speed (Bryden,
Roy, Rohr, & Egilo, 2007).
The current study required participants to complete both the place and remove
phase twice with each limb. The initial limb tested was randomly selected with the
subsequent testing order being the place phase followed by the remove phase, alternating
the limb. If a participant was unable to complete the task in five minutes, a count of pegs
completed was taken; the remove phase or a second trial of the place phase was not
completed. Participants completing the task in four to five minutes did not complete a
second trial with that limb and their first trial was taken as the average. These criteria
were enforced to ensure testing placed reasonable demands on participants. To include as
many participants in analysis as possible an average rate of time per peg was calculated
for each limb and phase and was used for data analysis.
Times from the GP were analysed separately based on the most and least affected
limbs. To determine the most and least affected side, a score was calculated using all side
related items of the UPDRS. Both upper and lower limb items were included (even
though the GP is an upper limb task) to determine the most degenerated side of the basal
ganglia, which corresponds to the contralateral side of the body with the most severe
symptoms. Thus, four rates resulted from each participant: affected and non-affected
place phase, and affected and non-affected remove phase.
The GP rates were compared with specific subsets of the UPDRS, selected to
represent the components of each phase of the GP. An upper limb affected and non-
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affected score was calculated for each side, using all upper limb side related items from
the UPDRS: 20 (resting tremor), 21 (action tremor), 22 (rigidity), 23 (finger taps), 24
(hand movements - open and close hands quickly), and 25 (rapid alternating movements
of hands - pronate and supinate). The upper limb subset was analysed with the place
phase of the corresponding limb to determine if a relationship existed. Secondly, an upper
limb bradykinesia score was calculated following previous work that used UPDRS items
23-26 to calculate a limb bradykinesia score (Marchese, Diverio, Zucchi, Lentino, &
Abbruzzese, 2000). The current study, however, utilized items 23-25 which represent
quick hand movements important to complete the GP quickly and not item 26 (leg
agility) which has no direct influence on the GP task. The limb bradykinesia score was
analyzed with the corresponding remove phase of the GP.

Spatiotemporal Aspects of Self-Paced Gait
Gait was measured as participants walked at their comfortable pace over a four
meter pressure-sensitive carpet (Gaitrite®, CIR Systems Inc., Clifton, NJ). Participants
began each trial a minimum of two steps before the carpet and continued walking a
minimum of two steps beyond the end of the carpet to ensure that acceleration and
deceleration did not contribute to the data collected. Five measurement trials were
averaged and used for statistical comparisons. The spatiotemporal aspects of gait
analyzed were step length and velocity as these are the gait characteristics most directly
evaluated as part of the UPDRS assessment.
Due to the potential confounding effect of height on a participant's step length the
step length values were divided by an individual's height. Height has no theoretical
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bearing on UPDRS scores, while decreased step length does as it is assessed as part of the
UPDRS. However, a person who is 180cm and takes a 45cm step is clearly more
impaired than a person who is 140cm and also takes 45cm steps. Thus, dividing step
length by height provided a more accurate reflection of impairment than step length
alone.
Velocity and step length were included as part of the regression analysis but were
not incorporated as part of the correlation analysis because only one item on the UPDRS
(29 - Gait) directly assesses self-paced velocity and step length; hence, no acceptable
UPDRS subset could be calculated.

Statistical Evaluation
Since the focus of the current study was not to identify differences between the
exercise interventions, pre-test scores from all exercise groups were collapsed. The first
analysis was a backward elimination linear regression to determine which outcome
measures were best able to predict overall UPDRS motor score, with F probability for
removal set at p >.10. Backward elimination regression was chosen due to the
exploratory nature of the model and the lack of theoretical predictions for outcome
measures that would be more influential on UPDRS score. This procedure allowed all
variables to enter the model and the least important predictors were removed until only
the most predictive variables remained. Measures from testing completed before
participants began the exercise program (pre-test) were used in the regression analysis.
Only participants that completed every testing component were included in the regression
and this represented 86 participants: two did not complete the Timed-Up-and-Go and
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twenty-three were missing grooved pegboard data (primarily participants that did not
complete the remove phase).
The second analysis was to examine the relationship between changes observed
on the outcome measures and the specific subset of the UPDRS for which they were
theoretically representing. The tests before commencement of the exercise program (pretest) and immediately following the exercise program (post-test) were used to determine
changes resulting from exercise. In an attempt to standardize the measures based on
disease severity (a five point change on the UPDRS carries different weight if pre-test
UPDRS score is twenty versus fifty), the difference from pre-test to post-test was
converted to a percent change for each outcome measure. The percent change calculation
was designed so a positive percent change signified improvement. For all outcome
measures included in the correlation analysis (UPDRS, TUG, GP) a lower score indicated
improved performance, the percent change calculation was: (pre-test - post-test)/pre-test
x 100%.
The specific relationships analyzed were: i) TUG and posture & gait (PG) score;
ii) GP place phase and upper limb UPDRS score (both affected and non-affected side);
and, iii) GP remove phase and upper limb bradykinesia score (both affected and nonaffected side). Participants unable to complete testing on one of the outcome measures or
whose results were deemed to be outliers with potentially excessive influence on the
relationship were removed from analysis pairwise. Outliers were generally the result of
participants with low scores in the UPDRS subsets, where a small change (1 or 2 points)
resulted in a large percent change. For example, one participant went from a 0.5 on the
PG score at pre-test to a 3.5 at post-test, representing a -600% change. To minimize the
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influence of large percent change on one variable, all percent changes with magnitude
greater than 100% were removed pairwise from the correlation analysis. Additionally,
participants with a score of 0 on a UPDRS subset at pre-test were removed from analysis
since an improvement beyond zero symptoms identified would be impossible (i.e.
denominator would equal 0). Thus, following these guidelines eight participants were
removed from the PG score; two from the TUG; six from the upper limb affected side
UPDRS score; fifteen from the place phase of the GP for the affected side; twelve from
the upper limb non-affected side UPDRS score; twelve from the place phase of the GP on
the non-affected side; nine from the affected side upper limb bradykinesia score; twentythree from the remove phase of the GP on the affected side; nineteen from the nonaffected side upper limb bradykinesia score; and, fifteen from the remove phase of the
GP on the non-affected side.
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RESULTS
Predicting UPDRS
All predictor variables were significantly correlated with overall UPDRS score,
and were normally distributed with no outliers (standardized residual of more than 3 std.
dev.) significantly influencing the regression model. Table 1 displays the mean and
standard deviation for each measure at pre-test. The first model included all seven
predictor variables and accounted for 0.326 (adjusted R2 = 0.266) of the variability in
UPDRS score with a linear regression equation of:
UPDRS = 17.189 - 0.045 (TUG) + 1.305 (GP Place Affected Side) + 1.292 (GP Place
Non-Affected Side) - 6.902 (GP Remove Affected Side) + 6.680 (GP
Remove Non-Affected Side) -0.045 (Gait Velocity) + 0.811 (Step
Length/Height)
However, this model violated a number of the assumptions of multiple regression,
namely multicollinearity typified by the step length/height variable which had a low
tolerance of 0.156, high variance inflation factor of 6.409, and a high condition index of
58.784. Additionally, in the first model the only predictor variable with a significant
contribution was the GP place phase on the affected side (t = 2.16, p = .034). Thus,
subsequent models were created as the predictor variables with the lowest partial
correlations with UPDRS score were removed. The order of removal was step
length/height (R2 change <.001), TUG (R2 <.001), gait velocity (R2 = -.01), GP remove
affected side (R2 = -.013), and GP remove non- affected side (R2 = -.005). Thus, the final
model included the GP place on the affected side and the GP place on the non-affected
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side and explained 0.297 (adjusted R2 = .280) of the variance in UPDRS with a standard
error of 7.06. The linear regression equation for the final model was:
UPDRS = 10.396 + 0.905 (GP Place Affected Side) + 1.971 (GP Place Non-Affected
Side)
While the model did pass most of the necessary assumptions of multiple
regression including independence of errors (Durbin-Watson = 1.698), normally
distributed residual error, and homoscedasticity; the high correlation between the two
remaining variables (r = .666) required careful consideration of multicollinearity. The
tests for multicollinearity were mostly passed (tolerance >.5, variance inflation factor <
2.5, condition indices < 15). Although, the condition indices were considered low ( < 9),
the high variance proportions (affected side = .65, non-affected side = .95) for the two
coefficients on the condition index for factor 3 raised concern of linear dependence and
multicollinearity problems. While the correlation between the place phases for affected
and non-affected limbs was understandable with the identical task being repeated for each
limb, both place phases were originally included in the regression analysis since they
might represent PD symptoms on the corresponding side. Since both place phases were
the only predictor variables left in the model following backward elimination regression
analysis, an additional model was analyzed using just the GP non-affected side to predict
UPDRS.
The non-affected side was chosen as it had a higher standardized Beta (Beta =
.367) than the affected side (Beta = .227); a higher variance proportion (.95 versus .65)
on the condition index for factor 3; and the test of prediction significance for the GP
place phase on the affected side was non-significant at a .05 level, (t=1.753, p >.05). This
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indicated that the GP place on the non-affected side was contributing more to the model
then the GP place on the affected side. The new model was significant (F = 30.837,
p<.001) and the GP place on the non-affected side was able to account for .269
(standardized R2 = .260) of the variability in UPDRS with a standard error of 7.16. The
prediction equation was:
UPDRS = 11.636 + 2.782 (GP place non-affected side).
Overall, the prediction model including the GP place phase for both the affected
and non-affected side of the body was significant and able to account for .297 of the
variability in UPDRS. The model containing only the GP place phase on the non-affected
side was also significant and still able to account for .269 of the variability in UPDRS (a
difference of only .028). Thus, the GP place phase on the affected side only accounted for
an additional 2.8% of the variability in UPDRS. The significance of the model containing
only the GP place phase for the non-affected side and the minimal increase in the percent
of UPDRS variability when the affected side is included suggests that multicollinearity
between the GP place phases on the affected and non-affected sides was a substantial
problem with the regression analysis.

Correlation analysis of symptomatic changes
None of the correlations investigated reached statistical significance. Table 2
displays the sample size, correlation coefficient and p-value for each of the relationships
investigated. The TUG and PG score relationship (r = -.036, p>.05); GP place phase and
corresponding upper limb score relationship (affected side, r = -.090, p>.05, non-affected
side, r = -.057, p>.05); and, GP remove phase and corresponding limb bradykinesia score
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relationship (affected side, r = .069, p>.05, non-affected side, r = -.009, p>.05) all had
low correlation coefficients suggesting that no relationships existed between the
variables.

44

DISCUSSION
Predicting UPDRS
The grooved pegboard (GP) was found to be the most useful tool to predict
UPDRS score. Specifically, the backward elimination regression analysis indicated that
the grooved pegboard (GP) place phase for both the affected and non-affected body side
were the best predictors of UPDRS score (accounted for .297 of the variability in
UPDRS). However, due to the multicollinearity between the variables a new model was
created using GP place phase on the non-affected side which was also significant and
able to account for .269 of the variability in UPDRS. Thus, the regression analysis
suggests that the place phase of the GP on the non-affected body side is the best predictor
of UPDRS scores.
The order of removal of the predictor variables from the regression model seems
to be logical for several reasons. The three gait related variables were the first to be
removed from the model. While gait is assessed as part of the UPDRS it is only directly
measured by one item. Due to the under-representation of gait measurement on the
UPDRS, changes in step length, velocity or the TUG are not likely to appreciably
influence change on the UPDRS. Also, gait variables were highly correlated with each
other and as witnessed in the first model violated assumptions of multicollinearity. It was
surprising, however, that the TUG was the second variable removed from the model. The
TUG measures sequential locomotor movements including walking and turning (Morris,
Morris, & Iansek, 2001) and has been suggested to be a clinical indicator of posture and
gait deficits that may be directly represented on the UPDRS such as sit-to-stand, gait,
postural stability and bradykinesia (Sage & Almeida, In Press). Since a significant
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correlation did exist between the TUG and UPDRS (and was higher than the correlation
between velocity and UPDRS, and also step length/height and UPDRS), further study is
warranted to investigate the utility of the TUG in identifying symptomatic changes in PD.
Conversely, the inclusion of the place phase of the grooved pegboard (both
affected and non-affected side, and non-affected side alone) in the final two models was
logical as a number of items measured on the UPDRS would directly affect performance
on the GP. UPDRS items 20 (resting tremor, measured separately for each limb), 21
(action tremor, measured separately for each upper limb), 22 (rigidity, measured
separately for each limb), 23 (finger taps, measured separately for each limb), 24 (hand
movements, measured separately for each limb), 25 (rapid alternating movements of the
hands, measured separately for each limb), and 31 (body bradykinesia) would have a
direct effect on performance on the GP. Thus, performance on the place phase of the GP
would be expected to have predictive utility for assessing symptoms measured with the
UPDRS.
The finding that an upper limb pegboard task was the most predictive UPDRS
scores is in line with previous work (Bohnen, Kuwabara, Constantine, Mathis, & Moore,
2007; Vingerhoets et al., 1997). Vingerhoets et al. found a significant correlation between
scores on a purdue pegboard and nigrostriatal dopaminergic deficit (Vingerhoets et al.,
1997), similar to our finding of a significant relationship between the grooved pegboard
UPDRS scores. More relevant to the current study, Bohnen et al. compared scores on the
place phase of the GP to nigrostriatal denervation and observed a significant correlation
between the least affected arm and denervation of the corresponding basal ganglia
(Bohnen et al., 2007). The finding was thought to be the result of a wide range of GP
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times and dopaminergic denervation on the least affected side, while no relationship was
found on the most affected side due to a statistical 'floor' associated with the more
severely denervated basal ganglia and a statistical 'ceiling' with GP times (Bohnen et al.,
2007). Since a rate (time/peg) was used to assess the GP, participants representing a wide
range of disease severities were included in analysis and the current study would not be
subject to the same degree of 'ceiling' effect on GP times. Hence, the current finding that
the relationship between the non-affected place phase of the GP and overall UPDRS
score (r = .518) had the highest correlation and was the best predictor of UPDRS scores
accurately confirms the findings of previous work.
Although there are limitations to the current models they are an intriguing starting
point. The two models were only able to account for less than 30% of the variability in
UPDRS, leaving a large portion (>70%) unaccounted for. To improve the predictive
power of the model, future studies might increase the sample size and investigate
additional variables that may account for UPDRS score. Additionally, adjustments to
improve the multicollinearity issues between the affected and non-affected side GP place
phases may benefit the model. It is unlikely that centering the data would appreciably
affect the multicollinearity of the two place phases as the tasks are identical. Similarly,
dropping the affected side place phase from analysis is not ideal as the GP place phase
from each limb is thought to be testing different aspects measured by the UPDRS.
Perhaps a future strategy would be to combine the variables (i.e. crossproduct) so that
both remain in the model as one new variable rather than two.
Given the originality of the current study, the final regression models (with either
both GP place phases or just the non-affected side) do provide a satisfactory starting point
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for prediction of symptom severity (as represented by UPDRS score). Unfortunately, the
models had a high standard error of prediction and only accounted for a low amount of
variability in UPDRS. The findings do suggest that other measures may be better
representations of PD symptoms. Of concern is the removal of all mobility measures in
the first steps of regression analysis which suggests that previous research that used
mobility outcome measures without also measuring PD symptoms provides an
incomplete picture. Functional mobility measures are easy to conduct and provide
important information; however, as they are not reflective of the UPDRS they do not
seem to provide disease specific information and must be interpreted cautiously.
Conversely, the UPDRS may be too focused on the upper limb and the lower limb and
mobility measures may be underrepresented. Ideally, future research would include
analysis of outcome measures that predict neurological functioning of the basal ganglia to
address the potential limitations of the UPDRS.

Correlation analysis of symptomatic changes
The correlational analysis was of particular importance to the current study as the
goal was to determine which outcome measures are best able to replicate clinical
symptomatic changes. Each outcome measure tested was carefully chosen as it was
thought to reflect specific PD symptoms, thus it was perplexing that none of the
relationships investigated reached statistical significance. Further, common methods to
increase power and improve the chances of finding significance such as increasing
sample size would not likely affect the relationships in the current study as the
correlations were very small (r < . 1, for all relationships) and the sample size was
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relatively large. Thus, the current findings suggest that none of the measures tested were
acceptable supplements of clinical assessment using the UPDRS.
One potential reason for the lack of relationship between the change on the
UPDRS subset and the corresponding outcome measure is the potential practice effect.
Bias should not be affecting the UPDRS assessment as the clinician was blinded and
participants cannot improve their ability on the UPDRS assessment (i.e. they cannot hide
their symptoms). However, the outcome measures may be subject to practice effects,
where a participant gains information about the TUG or GP and improves their
performance at post-test simply from a better understanding or greater experience with
completion of the required task. Thus, a participant may have an increased UPDRS
subset score (worsened symptoms) but still display an improvement on the GP or TUG.
This situation would decrease the magnitude of the relationship and may have been
present in the current correlation analysis as the Pearson's correlation coefficients were
all near zero. A scan of the posture and gait (PG) score and TUG percent improvements
displayed 15 participants that had an increased PG score (negative percent change) and
an improved TUG (positive percent change). Outcome measures that may be less
influenced by practice would be valuable to investigate, and may reveal the expected
relationship with UPDRS subsets.
Although the lack of relationship between the outcome measures and the
corresponding UPDRS subset is surprising, it speaks to the importance of combining
outcome measures with a PD symptomatic assessment to determine the disease specific
effect of the exercise technique. For example, Miyai et al. evaluated a mobility based,
body-weight supported treadmill training (BWSTT) program in two separate groups.
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While both groups realized mobility gains following exercise, the first group had
improved UPDRS scores and the second had no significant change on the UPDRS (Miyai
et al., 2000; Miyai et al, 2002). The mobility measures suggested that BWSTT was
beneficial in PD, but the UPDRS assessment suggested that BWSTT may not be
effective. Analysis of objective measures is important but should be considered in
relation to the specific aims of the exercise program. A mobility based program would be
expected to improve mobility in any population but without improvement in a symptom
specific manner, it may not be the optimal exercise strategy for use in PD. Thus, the lack
of relationship between the outcome measures and UPDRS subsets found in the current
study suggests that PD exercise rehabilitation trials without a PD symptomatic measure
provide an incomplete picture of the effects of the exercise intervention and should be
interpreted with caution. Nevertheless, functional outcome measures should not be
abandoned as they may reveal important changes representative of functional ability
within one's home environment.

Conclusions
The regression analysis suggested that the place phase of the grooved pegboard
(GP) was the best predictor of PD symptoms. The GP, or any measure of upper limb
motor control, however, has not been used extensively in PD exercise rehabilitation trials.
Future research should evaluate other objective measures that are representative of PD
symptoms and exercise trials should consider including an assessment of upper limb
motor control such as the GP. Unfortunately, the correlation analysis did not reveal any
objective outcome measures that reflected PD symptomatic changes identified through
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the UPDRS. As such, future work should continue to build on the current study to
determine the optimal outcome measures for use in PD exercise rehabilitation research.
As the relationship between objective measures and the UPDRS is unclear, both
should be included and results scrutinized to ensure that improvements are relevant in a
symptom specific manner before an exercise trial is deemed successful.
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Table 1 - Mean and standard deviation for each outcome measure at pre-test.

MEASURE

MEAN Std Dev

UPDRS
26.1
10.1
PG score
4.6
3.6
Affected side upper limb score
8.1
2.6
UPDRS Non-affected side upper limb score
4.5
2.7
subsets Affected side upper limb bradykinesia score
5.2
2.1
Non-affected side upper limb bradykinesia
score
2.9
2.0
TUG (s)
9.4
3.6
Affected side GP place phase (s/peg)
6.3
3.5
Non-affected side GP place phase (s/peg)
2.2
5.0
Objective
Affected side GP remove phase (s/peg)
1.2
0.3
Measures
Non-affected side GP remove phase (s/peg)
0.3
1.1
Velocity (cm/s)
24.0
113.1
Step Length (cm)/height (cm)
0.35
0.05
UPDRS, Unified Parkinson's Disease Rating Scale; PG, postur e and gait; TUG, timedup-and-go; GP, grooved pegboard.
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Table 2 - Sample size and correlation between percent change on objective outcome
measures and corresponding UPDRS subset.

RELATIONSHIP

SAMPLE
SIZE

CORRELATION

101
TUG & PG score
-.036
96
-.090
Affected side GP place phase & upper
limb UPDRS score
Non-affected side GP place phase &
93
-.057
upper limb UPDRS score
Affected side GP place phase & upper
85
.069
limb bradykinesia score
84
Non-affected side GP remove phase &
-.009
upper limb bradykinesia score
* significant at p<.05
TUG, Timed-Up-and-Go; PG, posture and gait; GP, grooved pegboard; UPDRS, Unified
Parkinson's Disease Rating Scale
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CHAPTER 3

A COMPARISON OF EXERCISE STRATEGIES TO IMPROVE THE MOTOR
SYMPTOMS OF PARKINSON'S DISEASE

ABSTRACT
The aim of the current study was to compare the effectiveness of four exercise
interventions (aquatic, aerobic, strength, and sensory attention focused exercise) and a
non-exercising control group to identify the optimal exercise strategy for individuals with
Parkinson's disease (PD). To improve upon shortfalls of previous research each exercise
intervention lasted an equivalent length of time and all participants were assessed by the
same evaluator, blinded to group assignment, using the Unified Parkinson's Disease
Rating Scale motor section (UPDRS). Testing was performed before exercises began
(pre-test), immediately following exercise (post-test) and following a minimum six week
non-exercise washout period (washout). Two statistical analyses were performed; the first
utilized all 89 participants and compared the pre-test to post-test assessments in the
exercise groups and the non-exercise control group. The second compared the four
exercise groups and included washout testing. Percent change scores were also calculated
to allow for adequate comparisons to be made between the groups regardless of pre-test
disease severity. Results indicated that the sensory attention focused exercise (PD
S AFEX) and strength training groups received the greatest benefit of exercise (pre-test to
post-test and percent change) compared to the non-exercise control group. The lasting
effects of the exercise interventions including the washout assessment was largely nonsignificant but suggested that the PD SAFEX, strength training had some long-term
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benefit. The methodological quality of the current study adds significant benefit to PD
exercise rehabilitation literature and suggested that PD SAFEX and strength training
warrant further exploration into their ability as an adjunct therapy in the treatment and
management of PD.
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INTRODUCTION

Parkinson's disease (PD) is a chronic neurodegenerative movement disorder
caused by a progressive deterioration of dopamine producing neurons in the substantia
nigra, pars compacta of the basal ganglia (Wolters & Francot, 1998). Current treatment
typically involves administering levodopa, a dopamine precursor that is metabolized to
dopamine in the periphery, to replace the lost dopamine in the basal ganglia (Leung &
Mok, 2005). Unfortunately, pharmacotherapy does not appear to delay the progression of
PD (Guttman, Kish, & Furukawa, 2003). As such, medications are stop gap measures that
are only able to mask the symptoms of PD, and alternative therapies are required to
complement pharmacotherapy to improve the outcome for individuals suffering from PD.
Alternative therapies may go beyond easing the physical impairments resulting
from PD and help ease the increasing financial costs associated with treatment of PD. In
Ontario, individuals with PD have been found to result in physician costs 1.4 times
higher, spend more time in hospital, and incur medication costs 3.0 times higher than
control subjects (Guttman, Slaughter, Theriault, DeBoer, & Naylor, 2003). Further, more
than 90% of individuals with PD were found to be over the age of 60 (Guttman,
Slaughter et al., 2003). With an aging society the prevalence of PD is likely to rise, thus,
relatively inexpensive, adjunct therapies are of increasing importance.
Evidence for the effectiveness of exercise as an adjunct therapy for PD has been
derived from animal models. Rats and mice that had been induced with mild to moderate
PD and exercised on a treadmill twice a day for only five (mice) or fifteen (rats) minutes
showed significant sparing of striatal dopamine, its metabolites, and dopamine
transporters compared to sedentary PD animals (Tillerson, Caudle, Reveron, & Miller,
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2003). Unfortunately, in humans a consensus on the effectiveness of exercise therapy for
PD has not been reached (de Goede, Keus, Kwakkel, & Wagenaar, 2001; Deane et al.,
2002).
Countless exercise interventions have been attempted in PD, however, results
have been inconsistent. Among the shortcomings, small sample size, variable lengths of
intervention, differences in outcomes measured, omission of control groups, lack of a
washout period are all factors that contribute to weak experimental designs. Exercise
strategies focused on increasing mobility have been the most commonly attempted
interventions (Johnson & Almeida, 2007), however, comparing exercise rehabilitation
research focused on mobility is still difficult. Nieuwboer et al. used auditory and visual
cues while exercising in participant's home environment and found increased gait and
step length measured over ten meters (Nieuwboer et al., 2007). Sunvisson et al. took
participants on daily walks through mountains to improve mobility and saw improvement
on a posturo-locomotor-manual test that had participants lift an object, carry it 150 cm
and place it on a shelf (Sunvisson, Lokk, Ericson, Winblad, & Ekman, 1997). Thaut et al.
utilized rhythmic auditory stimulation, infusing beats into music, to pace various gait
exercises and found increased step length and velocity measured over flat ground and up
a step and down a ramp (Thaut et al., 1996). While those research projects were focused
on mobility and generally found mobility improvements adequate comparisons between
them cannot be made, since measures are so different.
It should also be noted that mobility may be more easily influenced than
neurological symptoms (de Goede et al., 2001), hence, an even more important concern
with PD exercise research is the absence of a disease specific measure. Since the most
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common symptoms of PD are physical movement impairments (i.e. tremor, rigidity,
bradykinesia) it seems logical to include symptomatic measures such as the Unified
Parkinson's Disease Rating Scale (UPDRS). If a healthy individual participates in a
strength training intervention he would be expected to receive strength gains. Thus, if an
individual with PD participates in strength training and witnesses strength gains but no
disease specific symptomatic gains then it is reasonable to conclude that strength training
was beneficial in a musculoskeletal sense but was not successful at improving the
underlying neurological problems associated with PD and strength training may not be
optimal for individuals with PD. Numerous exercise rehabilitation studies have claimed
success without a symptomatic measure of PD (Caglar, Gurses, Mutluay, & Kiziltan,
2005; Cakit, Saracoglu, Gene, Erdem, & Inan, 2007; Li et al., 2007; Lokk, 2000;
Sunvisson et al., 1997; Thaut et al., 1996; Viliani et al, 1999) however, the actual disease
specific success of these interventions remains unanswered.
In the current study, four different exercise interventions and a non-exercise
control group were compared using identical lengths of intervention (including a nonexercise washout period), and participants were evaluated with the identical outcome
measures (including PD specific symptom measures). The exercise interventions
represented a range of typical exercise strategies used for PD, including aquatic based
exercise, aerobic exercise (using a machine specially designed for movement impaired
populations), and whole body strength training. Additionally, a sensory attention focused
exercise (PD SAFEX) program was employed to help patients focus on potential sensory
feedback deficits that have been recently identified in PD (Almeida et al., 2005; Jacobs &
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Horak, 2006). Thus, the overall purpose was to determine the optimal exercise strategy
for individuals with Parkinson's disease using a disease specific approach.
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METHODS
Participants
Eighty-nine individuals with Parkinson's disease were assigned to either aquatic,
aerobic, strength, sensory attention focused exercise, or were part of a non-exercise waitlist control group. Participants were assigned to groups based on the exercise centre that
was easiest to access and exercise interventions were administered based on the capacity
of each facility. Inclusion criteria included a diagnosis of idiopathic Parkinson's disease,
non-dementia, and a stable medication schedule. Participants were instructed to maintain
their current medication dosage and regular physical activity schedule for the duration of
the exercise intervention. Thus, the only addition to a participant's normal routine was
the exercise program they were administered. For the first component of the current study
twelve individuals participated in the aquatic exercise (0-F, 12-M; mean age=63.1,
SD=9.2); seventeen participated in aerobic training (8-F, 9-M; mean age=65.8, SD=9.9);
eighteen participated in strength training (9-F, 9-M; mean age=68.7, SD=8.3); twentyfour completed sensory attention focused exercise (PD SAFEX) (6-F, 18-M; mean
age=68.0, SD=T 1.0); and eighteen individuals were utilized in the non-exercise control
group (8-F, 10-M; mean age=68.6, SD=8.1). For the second component of the current
study, the non-exercise control group and individuals that did not complete the washout
testing were removed from analysis. It was common for participants to complete a twelve
week exercise session and then leave on holiday and be unavailable for washout testing.
Thus, forty-nine individuals were used for analysis of the second component. One
participant was removed from the aquatic group; three were removed from the aerobic
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group; seven were removed from the strength group; and, twelve were removed from the
PD SAFEX group.

Interventions
Each exercise program was administered 3 -times/week for 30 to 36 classes over
10 to 12 weeks depending on whether the program was completed in the fall, winter, or
spring (due to the holidays associated with the season). Non-exercise control participants
were instructed to maintain their normal physical activity routine for a 12 week period.
The aquatic exercise program was completed in a group setting over a one hour
period. The exercise distribution over the hour was approximately 20 minutes of
stretching and range of motion exercises on the pool side; 20 minutes of balance and
strengthening exercises in a chest deep pool using the water as resistance; and 20 minutes
of stretching and relaxation exercises seated on the pool edge with the feet in the water.
The exercises were modified from a seniors program at the Baycrest Centre for Geriatric
Care (Toronto, ON).
The aerobic intervention had participants training in groups of four, with each
participant using a BioStep® Semi-Recumbent Elliptical machine for 30 minutes per
training session. The machine was primarily leg driven as participants exercised in a
seated position. The movement pattern had the legs pushing forward, tracing an ellipse,
as the arms moved simultaneously in a coordinated pattern similar to walking. For
example, while pushing forward with the right leg, the left arm would also move forward
while the right arm and left leg moved backwards. Each exercise session consisted of a 5
minute warm-up, 20 minutes of aerobic training and a 5 minute cool-down. Exercise
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intensity was maintained by achieving: (i) a pace of 50rpm, (ii) a heart rate between 6075% of age calculated max, and (iii) a Borg rating of perceived exertion (RPE) below 5
on a 10-point scale. These criteria were monitored on a continual basis and recorded over
the final two minutes of the aerobic training portion of an exercise session. If the heart
rate and RPE were below the desired range for two consecutive sessions, resistance was
increased. Participants began training at a level of 20 Watts and each progressive increase
was approximately 15 Watts.
The strength training program was a whole body workout that targeted the major
muscle groups (chest, back, arms, abdominal muscles and legs) during each training
session. The exercises were completed individually during a designated hour long period
for the exercise group at a standard workout facility. Thus, it was a modified group
setting as each exercise was completed individually while group members shared the
exercise equipment. Three sets of 10-15 repetitions of each exercise were completed. As
the strength training progressed, weight lifted was increased as participants were able to
complete 3 sets of 14-15 repetitions, and weight lifted was maintained if participants
were able to complete 10-12 repetitions. Each participant filled out a log of the weight
lifted and number of repetitions which was inspected by a knowledgeable personal trainer
who oversaw the training sessions and adjusted the weight lifted as necessary. Two
YMCA training facilities were utilized to complete the strength training programs. The
two groups were compared and found to have equivalent responses to the exercises and
were combined into one strength training group for analysis.
The sensory attention focused exercise (PD SAFEX) was completed in a group
setting with approximately 10-15 participants, one head instructor and enough student
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volunteers to maintain a 2:1 ratio of participants to assistants. The volunteers were senior
undergraduate kinesiology students, many of whom were involved in a movement
disorders class, and all received training in the proper execution of the exercise program.
Volunteer training included instruction on common symptoms and behaviours associated
with PD as well as a description of the key components of the PD SAFEx program for the
volunteers to assist with. Each exercise class involved 20-30 minutes of non-aerobic gait
exercises, using a 75 meter circuit, which focused on body coordination followed by 2030 minutes of sensory attention exercises utilizing standard office chairs (All Seating
Corporation, Model No.3307) with latex Thera-bands® attached to the arm rests for
resistance. The core component of the exercises was to have participants focus their
attention on sensory feedback and awareness of their body in space. This was achieved
by dimming the lights in the exercise room and requiring participants to complete the
majority of the exercises with their eyes closed. Further, the instructor cued specific
sensory feedback from each exercise and the volunteers reinforced the sensory feedback
through verbal reminders and physically correcting improper body positioning. Each
week the exercises became progressively more challenging to participants body
coordination, balance and increased sensory feedback.
While a complete description of each exercise is beyond the scope of the current
manuscript a description of one of the gait exercises is provided to give further insight
into how the aims of the PD SAFEX program were achieved. A main component of the
gait exercises was coordinated movement patterns such as raising one leg to have the big
toe touch the opposite knee, while simultaneously swinging the contralateral hand to
contact the cheek/ear. For example, raise the right leg and have the right toe contact the
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left knee, at the same time swing the left arm to have the left hand contact the left
cheek/ear. Thus, a movement pattern similar to regular gait was required to complete this
exercise properly. As participants' eyes were closed they were forced to utilize only
tactile feedback from the contact between the toes and knee and the hand and cheek to
complete the required movement. Finally, balance was challenged as single leg stance
was required to bring the toes up to the knee. As the focus was not aerobic, volunteers
ensured each participant moved as slowly as necessary to properly complete each
component of the exercise. A more complete description of the PD SAFEX program has
been described elsewhere (Sage & Almeida, In Press) and has been included in appendix
A.
Participants could have participated in multiple exercise interventions; however,
to avoid the possible confounding effects of switching exercises, the current study
utilized participants who completed their first exercise intervention or had a minimum 15
week non-exercise period between the end of the first exercise program and the start of
the next program (only one participant was in both the SAFE and aerobic groups). Nonexercise control participants were utilized in analysis if the non-exercise period preceded
any exercise intervention (three participants were in both the SAFE and control groups
and three participants were in both the aerobic and control groups). All participants
signed informed consent letters before beginning the study and this research was
approved by the research ethics board at Wilfrid Laurier University.
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Evaluation
The primary outcome measure was a clinical assessment of Parkinsonian
symptoms using the motor section of the Unified Parkinson's Disease Rating Scale
(UPDRS) (Fahn, 1987). The UPDRS measures the symptoms of PD on using a five point
scale with zero representing no symptoms present and four representing the most severe
symptoms. Each item on the UPDRS represents specific symptoms of PD such as speech,
tremor, rigidity, gait and postural stability. Thus, the UPDRS provides an assessment of
global motor symptoms of PD. A certified and trained evaluator blinded to group
assignment performed all UPDRS assessments while participants were on their peak
dosage of Parkinsonian medication. Proper blinding of the clinician was achieved through
testing participants from multiple exercise groups and non-exercise control participants
on the same day in a random order. Participants were strictly instructed not to reveal their
group assignment to the clinician during assessment.

Statistical Analysis
The first comparison utilized all eighty-nine participants and compared the four
exercise groups with the non-exercise control group on their UPDRS scores. A group
(aquatic vs aerobic vs strength vs PD SAFEX vs non-exercise) x time (pre-test vs posttest) analysis of variance was performed to compare the different exercise interventions
and the non-exercising control group. While the ANOVA did pass the assumption of
homogeneity of variances, to control for potential differences at pre-test a percent change
was calculated for each participant by subtracting the post-test score from the pre-test
score and dividing by the pre-test score [(pre-test - post-test)/pre-test x 100%]. The
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percent change standardized the UPDRS changes as each participants change due to
exercise was compared to their individual pre-test level. The percent change was utilized
in a one-way analysis of variance to determine if the five groups differed on their percent
change. Statistical analysis followed intention to treat guidelines and significant main
effects and interactions were followed up using Tukey's post-hoc criteria.
The second comparison utilized the forty-nine participants that completed all
three round of evaluation: pre-test, post-test and washout. An exercise group (aquatic vs
aerobic vs strength vs PD SAFEX) x time (pre-test vs post-test vs washout) analysis of
variance using overall UPDRS scores was performed to compare the four exercise
groups. Again, the ANOVA did pass the assumption of homogeneity of variances, but
three percent changes were calculated to control for potential differences at pre-test: i)
(pre-test - post-test)/pre-test; ii) (post-test - washout)/pre-test; and iii) (pre-test washout)/pre-test. The percent change was utilized in a one-way analysis of variance to
determine if the four groups differed. Statistical analysis followed intention to treat
guidelines and significant main effects and interactions were followed up using Tukey's
post-hoc criteria.
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RESULTS
The five groups were of a statistically similar mean age and mean years since
diagnosis of PD. The aquatic group did not have any female participants and the PD
SAFEX group had a larger number of males than females, the other three groups had
nearly identical gender distributions. The strength training (mean=29.6) and non-exercise
control group (mean=24.6) had significantly different baseline disease severity measured
with the UPDRS. Table 1 provides a full breakdown of baseline participant
demographics.

Immediate Effects of Exercise
A significant group by time interaction was found for UPDRS scores, (F(4,84) =
4.60, p<.002) (Figure 1). Post-hoc revealed that both the PD SAFEX (pre-test = 27.2,
post-test = 20.5) and strength training (pre-test = 29.6, post-test = 24.1) groups
significantly improved their UPDRS scores from pre-test to post-test. Post-hoc revealed
that at pre-test the strength training group (mean = 29.6, SD = 11.0) had significantly
higher UPDRS scores than the non-exercise control group (mean = 24.6, SD = 9.3). The
non-exercise control group witnessed an expected small yet insignificant increase in their
UPDRS scores from 24.6 at pre-test to 25.1 at post-test. Comparison of the non-exercise
control group to the exercise groups at post-test displayed that the PD SAFEX (mean =
20.5, SD = 8.8) group had significantly less severe UPDRS scores than the non-exercise
control group (mean = 25.1, SD = 9.3).
The one-way ANOVA revealed that the five groups significantly differed on the
percent change in UPDRS scores from pre-test to post-test (F(4,84) = 6.36, p<.001)
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(Figure 2). Post-hoc revealed that the PD SAFEX (mean = 24.5%) and strength training
(mean = 18.6%) had a larger percent improvement then the non-exercise control group
(mean = -2.1%). The aquatic (mean = 12.0%) and aerobic (mean = 13.3%) groups did not
significantly differ from the non-exercise control group. A full breakdown of results is
provided in table 2.

Lasting Effects of Exercise
A significant time of test main effect was observed (F(2,90) - 14.3, p<.001)
indicating that UPDRS symptom severity scores were decreased at post-test compared to
both pre-test and washout. The group by time interaction approached significance
(F(6,90) = 1.97, p<.078) as UPDRS scores appeared to be reduced at post-test for the PD
SAFEX and strength training groups and the aerobic group appeared to have no change to
their UPDRS scores at all three testing times.
The percent change from pre-test to post-test one-way AN OVA narrowly missed
significance (F(3,45) = 2.7, p<.057) suggesting that the PD SAFEx and strength groups
appeared to have a greater percent improvement than the aquatic and aerobic programs.
No significant differences were identified for the post-test to washout percent change
(F(3,45) = 1.36, p<.267) or the pre-test to washout percent change (F(3,45) = 0.55, p<.65)
comparisons. A full breakdown of results is provided in table 3.
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DISCUSSION
The focus of the current study was to compare four exercise strategies and a nonexercise control group on their symptomatic benefit in PD. The first comparison of pretest to post-test scores for the four exercise groups and the non-exercise control group
suggested that strength training and PD SAFEX were the best strategies as they resulted in
significant improvement on UPDRS scores. Additionally, the PD SAFEX intervention
(24.5%) had the largest percent improvement followed by the strength training group
(18.6%). Similarly, when washout testing was included in analysis both the strength
training and PD SAFEX groups yielded the greatest symptomatic benefit. These results
were partially in line with the hypothesis, since the PD SAFEX group did realize the
greatest benefit of the exercise program along with the strength training group. The PD
SAFEX intervention may have improved the sensorimotor integration deficit in PD while
strength training may have improved neuromuscular transmission, both leading to
improved PD symptoms.
The non-exercise control participants provided a glimpse into the natural
progression of PD and were an important group to compare the exercise groups with. A
publication bias may exist in PD exercise rehabilitation literature as non-successful trials
are not reported (Deane et al., 2002). However, as PD is a progressive disease,
maintenance of pre-test disease severity could be considered a success. An adequate
control group allows for a more accurate determination of beneficial exercise
interventions and is a strength of the current study. Interestingly, only the PD SAFEX
group had significantly improved their UPDRS symptom severity scores to a level below
the non-exercise control group at post-test. This result must be interpreted cautiously as
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the strength training group, which saw a significant UPDRS improvement following
exercise, had a significant pre-test UPDRS score five points higher than the control
group. Thus, a large improvement for the strength training group and a substantial decline
for the control group were required for a significant difference to appear between these
groups at post-test. Nevertheless, the specific comparison of UPDRS scores between the
PD SAFEX group, which was two and a half points higher at pre-test, and the nonexercise control group is particularly intriguing as the PD SAFEX program was four and a
half points lower than the control group at post-test.
While the groups did not begin at equivalent disease severities the percent change
calculations was also a strength of the current study, since it allowed adequate
comparisons between the groups to be made. The percent change standardized the effects
of the exercise intervention by comparing each participant's UPDRS score change to
their own pre-test level. Further, the percent change calculation provides a different
dimension for comparison than the raw score analysis. For example, a participant with a
pre-test UPDRS of 50 that lowers their score by five points (10%) is very different from a
participant with a pre-test UPDRS score of 15 that lowers their score by five points
(33.3%). The percent change analysis of the current study demonstrated that the aerobic
and aquatic groups were not statistically different than the non-exercise control group,
indicating that these exercise strategies are likely not advisable for individuals with PD.
Further, the percent change analysis allowed for an important comparison to be made
between the strength training group and non-exercise control group, which revealed that
the strength training had a significantly greater percent change than the control group.
Similarly, the PD SAFEX program had a greater percent change than the control group.
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The end result of the pre-test to post-test percent change comparison was identical to the
raw score analysis in that the PD SAFEX and strength training programs appear to have
the greatest symptomatic benefit.
Including a six week no intervention washout period allows for assessment of the
lasting effects of exercise. Although, neither the UPDRS score interaction or any of the
percent change comparisons reached statistical significance they did reveal interesting
responses to the exercise interventions. The pre-test to post-test percent change was
nearly identical to the percent change comparison that included all participants, which
suggests that even though a large number of participants were removed from the washout
testing analysis the participants included were representative of their respective exercise
groups. Post-test to washout testing percent change was between -18 to -20 percent for
the aquatic, strength training and PD SAFEx groups, indicating that these three groups
saw an increase in their UPDRS scores from post-test to washout. While an increase in
scores was expected for the strength training and PD SAFEX groups as they had the
largest improvement at post-test; the large increase (-18.7 percent change) in the aquatic
group from post-test to washout after only a 10% improvement from pre-test to post-test
further suggests that the aquatic exercise program was not beneficial for individuals with
PD. Comparison of the pre-test to washout percent changes also suggests that aquatic
exercise is not beneficial for PD. While not statistically significant a -8 percent change
was observed in this group while the other three exercise groups ranged from 1.7 to 4.9
percent improvement. Thus, the percent change analyses suggest that PD SAFEX and
strength training provided the most direct benefit of exercise and these benefits appeared
to be maintained following the non-exercise washout period.
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The current study was internally strengthened by having participants exercise for
equivalent lengths of time and ensuring the same properly blinded clinician performed all
UPDRS assessments. Nevertheless, a few limitations are worth addressing. The aerobic
exercise utilized a specialized exercise machine that had theoretical potential to benefit
individuals with PD; particularly the coordinative movements of the arms and legs were
identical to that of gait which is disturbed in PD. However, this novel aerobic
intervention has only been investigated once previously (Sage & Almeida, In Press) and
this limits the comparison of the results of the aerobic intervention to previous aerobic
exercise interventions using more common techniques such as walking on a treadmill
(Cakit et al., 2007; Miyai et al, 2000; Miyai et al., 2002) or in the external environment
(Lokk, 2000; Sunvisson et al., 1997). It is worth noting that previous work by Sage &
Almeida involved a more comprehensive analysis of this aerobic intervention and
concluded that it was not the optimal exercise method for individuals with PD (Sage &
Almeida, In Press). A second limitation was the removal of a large number of
participants, particularly from the PD SAFEX group, from the washout testing analysis.
However, the pre-post comparisons of the UPDRS scores and the pre-test to post-test
percent change were nearly identical to the first analysis indicating that the participants
included in the washout analysis were representative of their respective group. Thus,
aside from a reduction in power due to the smaller sample sizes, the removal of
participants for the second analysis did not likely appreciably alter the results.
In a recent review, Deane et al. suggested a number of important criteria to
include in PD exercise research to address the shortcomings of previous research.
Amongst their suggestions were: use a large number of patients, use an adequate placebo
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therapy, follow patients after the exercise is stopped, and use disease specific measures
(Deane et al., 2002). The current study addressed all of these important suggestions,
which adds to the strength of the results. The group sizes were large, as even the twelve
participants in the aquatic program exceeded a number of commonly cited research
studies (Marchese, Diverio, Zucchi, Lentino, & Abbruzzese, 2000; Miyai et al., 2000).
The current study also utilized a non-exercise control group, followed participants
beyond the end of the exercise program and used the current gold standard for assessing
PD symptoms, the UPDRS.
While the current study alone is not sufficient to make final conclusions on the
optimal exercise strategy for individuals with PD, the methodological strength of the
current study is an important contribution to the search for the optimal exercise strategy
and suggests that PD SAFEX and strength training are more beneficial for individuals
with PD than aerobic or aquatic exercise.

Table 1 - Baseline participant demographics for the five groups

Gender

Age

Years Since
Diagnosis

UPDRS

Aquatic
63.1 (9.2) 7.7 (6.4)
28.5 (10.0)
0-F, 12-M
8-F, 9-M
26.9(11.8)
Aerobic
65.8 (9.9) 3.8 (3.9)
Strength
9-F,9-M
29.6(11.0)
68.7 (8.3)
5.7 (4.0)
6-F,18-M
27.2(10.2)
PD SAFE*
68.0(11.0) 5.1 (4.5)
Control
8-F, 10-M
68.6(8.1)
24.6 (9.3)
3.2 (2.8)
UPDRS, Unified Parkinson's Disease Rating Scale; PD SAFEX, sensory attention focused
exercise; Control, non-exercise control group
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Table 2 - Pre-test and post-test mean (±standard deviation) of Unified Parkinson's
Disease Rating Scale (UPDRS) scores and percent change of the four exercise groups and
the non-exercise control group. Percent change calculated as (pre-test - post-test)/pre-test
x 100%
Group
Pre-test (UPDRS Score) Post-test (UPDRS Score)
Percent Change (%)
28.5 (10.0)
25.0(8.7)
12.0(15.2)
Aquatic
27.2(10.2)
24.5
(20.8)
20.5 (8.8)
PD SAFEX
24.1 (9.6)
29.6(11.0)
18.6(17.0)
Strength
23.4 (8.7)
13.3(16.5)
26.9(11.8)
Aerobic
25.1
(9.3)
-2.1 (24.7)
24.6 (9.3)
Control
PD SAFEX, Sensory Attention Focused Exercise; Control, non-exercise control group
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Table 3 - Mean (±standard deviation) of Unified Parkinson's Disease Rating Scale
(UPDRS) scores, including washout and percent change of the four exercise groups.
Percent change calculated as (test 1 - test 2)/pre-test x 100%
Pre-test
Group
Post-test
Washout
Pre-test
Post-test
Pre-test
(UPDRS
(UPDRS
(UPDRS
to Postto
to
Score)
Score)
Score)
test (%
Washout Washout
Change)

(% Change)

(% Change)

Aquatic
29.3(10.0) 25.9 (8.6) 31.5(11.2) 10.7(15.9) •18.7(16.5) -8.0(15.5)
PD SAFEX
24.7 (9.7)
19.2(10.0) 22.7 (6.4) 23.6(23.3) -20.3(38.1) 3.2 (27.0)
Strength
28.9(12.7) 23.1 (10.3) 27.8(12.0) 19.9(16.7) -18.1 (27.8) 1.7(25.2)
5.0 (34.0)
26.5(12.8) 23.7(9.6)
22.8(7.9)
5.5(15.3)
-0.5(28.7)
Aerobic
PD SAFEX, Sensory Attention Focused Exercise; Control, non-exercise control group
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Figure 1 - Comparison of UPDRS scores before exercise began (pre-test) and
immediately following the end of the intervention (post-test). * denotes significance at
p<.01. # denotes significance at p<.05.
PD SAFEX, Sensory Attention Focused Exercise; Control, non-exercise control group.
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Figure 2 - Comparison of percent change on the Unified Parkinson's Disease Rating
Scale following exercise, calculated as pre-test - post-test/pre-test x 100%. Note that
positive percent change indicates improved Parkinson's disease symptoms. * denotes
significance at p<.001.
PD SAFEx, Sensory Attention Focused Exercise; Control, non-exercise control group.
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CHAPTER 4

THE EFFECT OF INCREASED SENSORY FEEDBACK DURING EXERCISE IN
PARKINSON'S DISEASE

ABSTRACT
Deficits integrating and utilizing proprioceptive information especially during
self-motion have been identified in Parkinson's disease (PD) (Almeida et al., 2005). The
current study evaluated the effect of increased attention on sensory feedback during
exercise. Two twelve week long exercise programs that differed only in the presence (PD
SAFEX) or absence (non-SAFE) of increased attention focused on sensory feedback were
compared symptomatically using the Unified Parkinson's Disease Rating Scale
(UPDRS). Participants were assessed before the start of the exercise program (pre-test),
immediately following the 12 week program (post-test) and after a minimum six week
non-exercise washout period (washout). Secondary outcome measures included the
Timed-Up-and-Go (TUG), Grooved Pegboard (GP) and velocity and step length of selfpaced gait. The UPDRS symptom severity scores revealed that only the PD SAFEx
program significantly improved PD symptoms and that gains were maintained following
a six week non-exercise washout period. The TUG, GP, velocity and step length did see
some improvement following exercise but no differences were observed between the
exercise groups. The results suggest that symptom specific measures such as the UPDRS
are a critical component of exercise rehabilitation research, to ascertain whether benefits
of exercise are general musculoskeletal benefits or disease specific neurological benefits.
Further, increased focus on sensory feedback appears to benefit exercise programs as it
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resulted in improved PD symptoms that were maintained after the intervention was
stopped.
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INTRODUCTION
Parkinson's disease (PD) is a disorder of the basal ganglia caused by a
deterioration of dopamine producing neurons in this area; it is estimated that 70% of
these neurons are lost before motor symptoms are detectable (Wolters & Francot, 1998).
The physical symptoms of PD include tremor, rigidity, postural instability, bradykinesia
(slowness of movement), and akinesia (absence of movement) (Guttman, Kish, &
Furukawa, 2003). To combat PD symptoms numerous exercise approaches such as
treadmill walking (Miyai et al., 2000; Miyai et al., 2002) or traditional physical therapy
(Ellis et al., 2005) have been attempted with conflicting results (de Goede, Keus,
Kwakkel, & Wagenaar, 2001; Deane et al., 2002). An important consideration is that
perhaps, these approaches are not the ideal exercise model as they were designed based
on the musculoskeletal PD deficits such as rigidity or altered gait and not the underlying
neurological deficits causing the visible motor symptoms.
More recently exercise strategies that have attempted to improve disease specific
symptoms and movement deficits in PD have been investigated and shown promising
results. Cueing is the primary symptom specific strategy that has been employed in rehab
settings based on research displaying that auditory and visual cues can improve the
disturbed gait present in PD (Lewis, Byblow, & Walt, 2000; M. E. Morris, Iansek,
Matyas, & Summers, 1996; Rubinstein, Giladi, & Hausdorff, 2002). The largest study
involving 153 participants trained using visual and auditory cues found increases in
velocity, step length and posture and gait, measured as a subset of the Unified
Parkinson's Disease Rating Scale (Nieuwboer et al., 2007). Similar success was found by
Thaut et al. where rhythmic auditory stimulation (synchronized beats to music) during
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gait exercises was found to increase cadence, velocity and stride length following
exercise (Thaut et al., 1996). Further, del Olmo et al. also found improvements in
spatiotemporal aspects of gait following exercises paced by a metronome (del Olmo &
Cudeiro, 2005). Two main limitations were present in this research. The first was that the
exercise and outcome measures used were primarily gait focused and as suggested in a
review by Deane et al., specific impairments such as decreased step length can be easily
altered but may not benefit a patient's day to day activities (Deane et al., 2002). The
second limitation was that only Nieuwboer et al. (2007), who used a subset of the
UPDRS, utilized any clinical measure of the symptoms of PD. Thus, it was difficult to
ascertain whether the mobility benefits resulting from cueing exercise were in fact
disease specific symptomatic gains or only very specific mobility gains. Utilizing PD
symptom specific measures such as the UPDRS should be incorporated as an outcome
measure in exercise rehabilitation research to allow evaluation of exercise trials in a
disease specific symptom manner.
Few studies have addressed the previously identified limitations. The del Olmo et
al. group built on their previous research by examining changes using positron emission
tomography (PET) and found cortical changes after cueing exercise that suggested
cortical reorganization to bypass the defective basal ganglia (del Olmo, Arias, Furio,
Pozo, & Cudeiro, 2006). Another approach taken by Marchese et al. utilized a cued and
non-cued group and a clinical measure of PD symptoms, the UPDRS. Both groups were
found to benefit from the exercise, however, following a six-week non-exercise period
only the cued group retained the benefits of the exercise program (Marchese, Diverio,
Zucchi, Lentino, & Abbruzzese, 2000). These limited results point to potential benefit of
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sensory cues, however, further well designed research into the benefit of sensory based
PD exercise rehabilitation programs is needed.
The current study builds on the previous work completed at our research center
which identified functional improvements following Sensory Attention Focused Exercise
(PD SAFEX) (Sage & Almeida, In Press). Research has suggested that individuals
suffering from PD have a deficit in their ability to integrate and utilize sensory,
specifically proprioceptive feedback (Almeida et al., 2005; Jacobs & Horak, 2006). This
deficit may stem from the dysfunctional basal ganglia which has been suggested to play
an important role in the integration of proprioceptive feedback during movement
(Almeida et al., 2005). The PD SAFEX program was designed to help guide participants
to focus on and utilize proprioceptive feedback, thus, improving awareness of self motion
during the performance of each exercise. To obtain this goal, exercises were done in the
dark, with eyes closed and instructions keyed participants' attention to specific sensory
markers (i.e. 'feel your toes touch your knee') needed to effectively complete each
exercise.
The purpose of the current study was to evaluate whether increased attention on
sensory and proprioceptive feedback during the PD SAFEX program has a specific
influence on the symptoms of PD. As such, a modified PD SAFEX program that involved
identical exercises but lacked the increased attention on sensory and proprioceptive
feedback (non-SAFE) was compared to the PD SAFEX intervention to determine the
effect of increased sensory feedback attention in PD. Symptom specific measures
(UPDRS) and traditional measures (spatiotemporal aspects of gait, timed-up-and-go, and
grooved pegboard) were used to improve on deficits identified in previous exercise
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rehabilitation literature and to evaluate the effectiveness of the exercise programs on a
wide range of PD specific symptomatic deficits. Three testing periods were used
including a pre-test before the exercises began, a post-test administered immediately
following the end of the exercise program and a minimum six week non-exercise
washout period. The washout period was of particular importance because it allowed for
an evaluation of the lasting effects of the exercise programs and provided insight into
whether improvement on outcome measures was due to increased musculoskeletal fitness
or neurological improvements.
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METHODS
Participants
From September 2006 to August 2007, the PD SAFEX and non-SAFE exercise
programs were administered simultaneously at the Movement Disorders Research and
Rehabilitation Centre (MDRC) at Wilfrid Laurier University over three 12-week sessions
with a six week non-exercise washout period separating each session. While 48
participants were involved, the current study examined the 26 participants with idiopathic
PD who completed either the PD SAFEX (n=13; mean age=66.1, UPDRS=24.7) or the
non-SAFE (n=13; mean age=66.8, UPDRS=20.2) program and all three rounds of testing
(pre-test, post-test, washout). Since some participants were involved in multiple exercise
sessions (fall, winter, summer) the 26 participants used in the current study were
participating in their first exercise session at the MDRC. The majority of participants
excluded from the current study were eliminated because they missed a testing session;
often due to travel requirements (i.e. exercised during the fall session and then went down
south for the winter and missed washout testing).
All participants had a diagnosis of PD with no other major neurological or
psychological problems. All medication and supplementary physical activity was
unaltered for the duration of the study such that the only addition to a participant's
regular schedule was the exercise program they were administered. This research was
approved by the research ethics board at Wilfrid Laurier University and all subjects
signed informed consent forms before commencement of the study.
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Exercise Interventions
Participants were randomly assigned to either participate in the full PD SAFEX
program or the non-SAFE program. Both exercise interventions required participants to
attend three times per week for approximately one hour, with the main difference
between the programs being the lack of sensory focus in the non-SAFE program. A more
complete description of the PD SAFEX program has been published previously (Sage &
Almeida, In Press) and is provided in appendix A. Briefly, however, both programs were
group settings with approximately fifteen participants, one instructor and enough student
volunteers (senior undergraduate students at WLU trained in proper administration of the
exercise program) to maintain a 2:1 ratio of participants to volunteers. The volunteers
were present to ensure participants' safety and to reinforce the sensory cues for the
participants. There were approximately 30 minutes of non-aerobic gait exercises followed
by 30 minutes of exercises using office chairs (All Seating Corporation, Model No.3307)
with latex Thera-bands® attached to the arm rests for light resistance. The PD SAFEX
exercises were designed to have participants focus on their sensory feedback by dimming
the lights, having participants close their eyes, and cueing them to specific portions of the
exercises. The non-SAFE program mirrored the PD SAFEX program, with the exception
of the focus on sensory feedback as the lights were on, participant's eyes were open, and
the instructions did not cue participants to sensory feedback.
An example of the instruction of the same exercise provided to both programs
may highlight the different aims of the two programs. A simple hamstring stretch was
performed in a seated position with the foot rested on the seat of the chair and the arms
pulling the leg in to the chest. The non-SAFE program completed the exercise with eyes
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open, lights on and received general instruction to bring their foot onto the chair and pull
the leg towards the chest. The PD SAFEX program completed the exercise with their eyes
closed and lights off forcing them to rely only on tactile and proprioceptive feedback.
The instructions were to maintain contact between the calf and the front edge of the chair
while raising the leg up. Once the heel reached the seat of the chair, the foot was rested
on the seat of the chair and the leg pulled into the chest. While holding the stretch
participants were instructed to focus on the feeling of the stretch in their hamstring. On
the second set of the stretch, participants were instructed to ensure the feeling of the
stretch was identical to the first set, which provided feedback that they were performing
the exercise properly. The different instructions and procedures to complete a simple calf
stretch display the different focuses of the PD SAFEX and non-SAFE exercise programs.

Evaluation
Participants were evaluated at three separate time periods: (i) before commencing
the exercise intervention (pre-test); (ii) immediately following the last exercise session
(post-test); (iii) a minimum of six weeks following the end of the exercise intervention
(washout).
The primary outcome measure was a clinical evaluation consisting of the Unified
Parkinson's Disease Rating Scale motor section (UPDRS) (Fahn, 1987) which measured
symptoms of PD on a five point scale with four representing the most severe symptoms
and zero representing no symptoms present. The UPDRS was administered at
participants' peak anti-Parkinsonian medication dosage by a trained evaluator blinded to
participants' group assignment. Blinding was achieved by testing participants from both
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exercise groups in random order on the same day as participants from other research
projects and instructing participants not to reveal group assignment to the clinician. The
UPDRS motor section was further broken down into subsets incorporating all items with
both a left and right side component to assess changes to the most and least affected body
side to provide insight into neurological changes corresponding to the most and least
denervated side of the basal ganglia.
Upper limb motor control was assessed using the Grooved Pegboard (GP)
(Lafayette Instruments, Lafayette, IN). Participants completed two trials with each hand
following a procedure previously outlined (Bryden & Roy, 2005). Each trial consisted of
both a place phase where 25 grooved pegs were placed into key shaped holes and a
remove phase where the pegs were subsequently removed using the same hand. The order
of limb testing was started randomly and then alternated between the limbs until both
limbs had completed the procedure twice. All participants were self reported right-handed
and the place and remove phases of the GP were analyzed based on the most and least
affected body side, as identified using the UPDRS scores at pre-test. Participants
completing the GP in more than four minutes did not complete a second trial and
participants unable to complete the grooved pegboard in five minutes were stopped, a
count of pegs completed was taken, and the remove phase was not completed. This was
done to avoid the frustration associated with spending twenty to thirty minutes
completing the GP. To include as many participants in analysis as possible an average
rate of time(s) per peg for the two trials was averaged for each participant and used in
statistical analysis. Three participants were removed from analysis of the remove phase
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using the affected limb and one participant was removed from analysis of the remove
phase using the non-affected limb due to failure to complete the task.
Gait was measured in a functional task using two trials of the Timed-Up-and-Go
(TUG), which has been shown to be a reliable outcome measure in PD (S. Morris,
Morris, & Iansek, 2001). Each trial had participants' begin from a seated position, stand
up, walk three meters, turn around, return to the chair and sit down as quickly as possible.
Spatiotemporal aspects of gait including velocity and step length were measured using
five trials of self-paced gait over a four meter pressure sensitive GAITrite® carpet. Each
trial began a minimum of two paces before the carpet and the participant continued
walking a minimum of two paces after measurement ceased to ensure that acceleration
and deceleration were not included in measurement.
Statistical analysis was completed using Statistica® software with an alpha level
of 0.05. Each outcome measure was analyzed using group (PD SAFEX vs non-SAFE) by
time (pre-test vs post-test vs washout) analysis of variance. Significant ANOVA's were
followed up using Tukey's HSD post-hoc procedure. The post-hoc comparisons of
particular importance were the pre-test to post-test and post-test to washout comparisons,
which indicate the immediate and lasting effect of the exercise programs respectively.
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RESULTS
The two groups were not significantly different on their mean age, years since
diagnosis or disease severity (measured with the UPDRS). Baseline demographics of the
two exercise groups are outlined in table 1. A complete breakdown of all results is
provided in table 2.

Clinical Evaluation
The UPDRS symptom severity score analysis revealed a significant group by time
interaction (F(2,48) = 3.62, p<.035) figure 1. Post-hoc indicated that only the PD SAFEX
group improved their UPDRS scores at post-test compared to pre-test (p<.035) and
maintained the improvements from post-test to end of washout (p>.05). The non-SAFE
group did not appreciably alter their UPDRS scores following exercise, however, after
the washout period the UPDRS scores were significantly higher (i.e. symptoms
worsened) than at post-test (p<.035).
Side affected UPDRS analysis identified main effects of time for both the affected
(F(2,48) = 8.90, p<.001) and non-affected (F(2,48) = 5.23, p<.01) sides of the body,
figure 2a & 2b. On the affected side of the body the post-test significantly improved
compared to both the pre-test and washout, suggesting that symptom severity was
decreased following exercise. The non-affected side of the body revealed no significant
UPDRS change from pre-test to post-test but scores were significantly higher (i.e.
symptoms worsened) at washout. A group by time interaction for the affected side
narrowly missed significance (F(2,48) = 3.09, p<.055) hinting that the PD SAFEX
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program was associated with greater improvements, since UPDRS scores from pre-test to
post-test improved by 27.4% while the non-SAFE had only improved by 4.3%.

Upper Limb Motor Control
Both the affected (F(2,42) = 5.62, p<.007) and non-affected (F(2, 46) = 13.07,
p<.001) sides of the body displayed main effects of time for the remove phase of the GP
indicating that post-test had a significantly faster rate (time/peg) than the pre-test, and
that this improvement was maintained after the washout period (see figure 3a & 3b). The
place phase of the grooved pegboard did not reveal any significant effects or interactions
on either the affected or non-affected sides of the body.

Gait
A significant main effect of time for the TUG was found (F(2,48) = 4.69, p<.014)
demonstrating that gait was significantly faster at post-test (compared to pre-test) and that
these improvements were maintained after the washout period (see figure 4).
Step length also revealed a main effect of time (F(2,48) = 3.28, p<.046) with a
significantly increased step length at post-test compared to both pre-test and washout.
Velocity approached significance for a main effect of time (F(2,48) = 2.82, p<.069) with
participants appearing to have increased velocity at post-test compared to pre-test.
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DISCUSSION
The aim of the current study was to determine the effect of increasing attention to
sensory feedback during exercise rehabilitation. Two identical exercise interventions
were administered, differing only in the presence (PD SAFEX) or absence (non-SAFE) of
focus on sensory feedback. As hypothesized, the increased focus on sensory feedback in
the PD SAFEX program had the greatest influence on the clinical measure of PD
symptoms (UPDRS), which was maintained following six weeks of inactivity. These
findings are similar to the findings of Marchese et al. who utilized a comparable study
design and found that two similar exercise programs, differing only in the presence or
absence of sensory cues, displayed improved UPDRS symptom severity scores.
However, only the sensory cued group maintained the improvements following six weeks
without the exercises (Marchese et al., 2000). Interestingly, in the current study, all other
changes as a result of exercise, including improved GP remove phase, TUG, and step
length were main effects suggesting that both exercise programs were able to positively
affect these measures.

Clinical (UPDRS) Outcomes
The primary outcome measure (clinical assessment of PD symptoms using the
UPDRS) was the only outcome measure to reveal group differences through a group by
time interaction. While participants were randomly assigned to groups and there was not
a significant difference in UPDRS scores at pre-test, the non-SAFE group (mean = 20.19)
was four points lower than the PD SAFEX group (mean = 24.73). Thus, it could be
suggested that the PD SAFEX group had a larger capacity to improve their UPDRS motor
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scores than the non-SAFE group. Examining UPDRS scores in more depth demonstrates
that the PD SAFEX group improved their scores by 22%, while the non-SAFE group only
improved theirs by 5% from pre-test to post-test. Previous research involving the PD
SAFEX program also displayed similar results as 18 individuals with PD improved their
UPDRS scores from 22.5 to 16.9, or 25% following 12 weeks of exercise (Sage &
Almeida, In Press). Thus, the results of the current study were expected as they replicated
findings previously reported. Interestingly, at post-test, both groups had identical UPDRS
scores of 19.2 yet following the six week non-exercise period the non-SAFE groups mean
UPDRS score had significantly worsened by 5.5 points while the PD SAFEX group
maintained some of the benefits of exercise as their mean score insignificantly increased
by only 3.42 points. Thus, the increased attention on sensory feedback present in the PD
SAFEX program appears to benefit symptom severity of PD with improved symptoms
maintained after the exercise was stopped.

Changes Associated with Side Affected
While the UPDRS motor scores revealed between group differences, the subsets
corresponding to the affected and non-affected body sides did not. While only
approaching statistical significance, the PD SAFEX group had greater improvement on the
affected side in response to the exercises, witnessed by improvements of 27.4% and
15.0% compared to 4.26% and 4.54% for the non-SAFE group on the affected and nonaffected sides of the body respectively. The improved scores in the PD SAFEX group may
have driven the main effect; however, the group sizes may not have been large enough to
display a significant interaction. These results were interesting, and to the best of the
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author's knowledge the current study was the first to use this subset as an outcome
measure and further exploration in future research is needed.
Affected vs. non-affected side related symptomatic changes may be of greater
importance than overall UPDRS change, since the comparison provides a clinical
measure of the functioning level of the most and least denervated basal ganglia. Thus, the
comparison will aid in determining the influence of exercise on different levels of
dopaminergic neuronal denervation. Evaluating the influence of exercise on differing
functional levels of the basal ganglia is important as previous rodent models induced with
chronic PD suggested that at more severe disease progressions the mice were able to
improve cardiovascular and musculoskeletal function but unable to improve neurological
function following exercise (Al-Jarrah et al., 2007). Conversely, rats and mice induced
with mild PD were able to improve neurological function, witnessed by a sparing of
striatal dopamine, following exercise (Tillerson, Caudle, Reveron, & Miller, 2003). Thus,
continuing to compare PD symptoms on the most and least affected body sides may
provide an indication of neurological changes in the basal ganglia and aide in
determining the influence of exercise on different levels of pre-exercise basal ganglia
functioning.
Changes associated with affected side were not identified through the grooved
pegboard (GP), since neither group improved their time on the place phase and both
groups improved their time on the remove phase for both affected and non-affected body
sides. The place phase is a visuo-motor task while the remove phase is more a measure of
motor speed (Bryden & Roy, 2005). As the participants in the current study were
primarily older individuals, perhaps, the place task was too demanding for them. This is
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supported by the observation that six participants (approximately 25%) required more
than four minutes to complete the task or were unable to complete it. However, as the
place phase analysis included all participants using a time per peg rate, and the
participants that took longer to complete the task had a greater capacity to improve and
positively influence the group results, it is more likely that neither exercise program was
able to appreciably improve fine visuo-motor control. The remove phase does not require
the same accuracy demands and both exercise groups did improve their rate on the
remove phase indicating improved upper limb motor speed. Specific to PD symptoms the
remove phase may be an indicator of improvement in one of the cardinal symptoms of
PD, bradykinesia (slowness of movement) and thus the results suggest that both exercise
programs improved upper limb bradykinesia. Since a number of exercises in both
interventions required fine control of limb position, perhaps, individuals were able to
improve upper limb movement efficiency, as suggested by the decreased time taken to
remove the pegs.

Analysis of Gait
Locomotion was improved in both groups following exercise, supported by the
main effect of time for the TUG. These results may be relevant to PD symptoms as the
TUG specifically evaluates motor impairment issues that are commonly associated with
PD such as sit to stand, initiation of gait, and dynamic balance while turning. Thus, both
exercise programs improved locomotion and motor impairment following exercise and of
further interest, the benefits were maintained in both groups following the six week nonexercise period.
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The improvements in gait following exercise were minor, as the significant main
effect of step length at post-test was the result of a two cm increase, and no group
differences were identified. However, the combined increases in velocity and step length
are suggestive of a more normalized gait pattern. Minimal improvements were not
unexpected as neither exercise program had a specific focus on gait. Further, specific
impairments such as spatiotemporal aspects of gait have been shown to be easily
influenced but are suggested to be inconsequential to a patients day to day life (Deane et
al., 2002). Thus, the minor gait improvements identified in the current study are
secondary as the focus was on a global improvement of PD symptoms.

Conclusion
The main effects of time observed in the objective outcome measures including
the TUG, GP, and self-paced gait did not reveal any group differences since no
significant group by time interactions were found. This suggests that the specific
exercises of the intervention have the capacity to improve many movement
characteristics and potentially functional outcomes (which may represent functional
abilities in the home environment). Additionally, increased focus on sensory feedback in
the PD SAFEX intervention led to an additive benefit in terms of decreased motor
symptoms. Thus, the combined improvements on the objective measures and the UPDRS
witnessed in the PD SAFEX program are more disease specific and display the benefit of
increasing focus on sensory feedback in an exercise rehabilitation intervention.
An additional strength of the current study was the continued evaluation of
participants following a non-exercise washout period. The lasting effects in the PD
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SAFEX group on the UPDRS suggests that the improvements following exercise with
increased focus on sensory feedback are not simply musculoskeletal but the result of
improved neurological functioning. While the exact mechanism behind the improved
motor symptoms in PD is unknown two speculative mechanisms are: i) new pathways
were formed in the brain to bypass the dysfunctional basal ganglia, or ii) The increased
sensory feedback traveling through the basal ganglia is resulting in improved functioning
of the remaining dopaminergic neurons. While the exact mechanism behind the improved
motor symptoms of PD remains unknown, of more importance is the fact that increased
attention on sensory feedback in the PD SAFEX program resulted in lasting symptomatic
improvements.
The main difference between the two exercise programs was the focused attention
on sensory feedback. Increased focus on sensory feedback in the PD S AFEX group
resulted in improved clinical symptoms, which were maintained after exercise ceased,
while the non-SAFE group did not realize the same symptomatic benefits. As the primary
focus was on global improvement in PD symptoms the results do suggest that increased
attention on sensory, specifically proprioceptive, feedback is a beneficial addition to
exercise programs for individuals with PD.
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Table 1 - Mean (±standard deviation) baseline participant demographics for the two
groups
^______^

Group

Gender

Age

Years Since
Diagnosis

UPDRS
66.1(11.3) 4.2 (4.3)
PD SAFEX
24.7 (9.7)
F-3.M-10
66.8 (9.0)
3.2 (2.9)
20.2 (7.6)
non-SAFE
F-6, M-7
UPDRS, Unified Parkinson's disease rating scale; SAFE, sensory attention focused
exercise

Table 2 - Mean (±standard deviation) of outcome measures that revealed significant
main effects resulting from Sensory Attention Focused Exercise (PD SAFEX) and nonSAFE.
Measure
Test
Non-SAFE
PD SAFEX
Pre-test
24.7 (9.7)
20.2 (7.6)
UPDRS (Score)
Post-test
19.2(10.0)
19.2 (9.3)
Washout
22.7 (6.4)
24.7 (7.6)
Pre-test
10.4 (2.6)
10.0(2.4)
UPDRS Affected Side (Score)
Post-test
7.5 (2.8)
9.5 (2.7)
Washout
9.8 (3.3)
11.8(3.3)
Pre-test
5.7 (2.4)
4.2 (2.4)
UPDRS Non-Affected Side
4.0 (3.2)
Post-test
4.8 (2.8)
(Score)
Washout
6.1 (3.1)
5.8(3.1)
Pre-test
1.3 (0.4)
1.4(0.2)
Grooved Pegboard Affected
Post-test
1.1 (0.2)
1.0(0.2)
Side Remove Phase (sec/peg)
Washout
1.1(0.2)
1.1 (0.2)
Pre-test
1.2(0.3)
1.2(0.3)
Grooved Pegboard NonPost-test
1.0(0.3)
1.0(0.3)
Affected Side Remove Phase
Washout
1.0(0.3)
1.0(0.2)
(sec/peg)
Pre-test
11.2(6.6)
8.0 (2.6)
Timed-Up-and-Go (seconds)
Post-test
7.6 (3.2)
9.6(3.5)
Washout
7.6 (2.7)
9.2 (4.7)
Pre-test
57.0 (9.4)
61.4(9.4)
Step Length (cm)
Post-test
61.8(9.1)
60.2 (8.0)
Washout
61.2(8.1)
61.2(8.9)
Pre-test
109.0 (24.6)
121.2(19.6)
Velocity (cm/sec)
Post-test
117.8(18.9)
122.3 (18.3)
Washout
121.2(15.7)
116.2(22.7)
UPDRS, Unified Parkinson's Disease Rating Scale
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m Pre-test
D Post-test
£3 Washout

PD SAFEx

Non-SAFE

Figure 1 - Unified Parkinson's Disease Rating Scale (UPDRS) scores at pre-test, posttest, and washout for the two exercise groups. * denotes significance at p<.05.
SAFE, Sensory Attention Focused Exercise
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Figure 2a - Main effect of time for the affected side related changes on the Unified
Parkinson's Disease Rating Scale (UPDRS). Significant main effect at p<.001, post-test
was significantly less severe than pre-test and washout.
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Figure 2b - Main effect of time for the non-affected side related changes on the Unified
Parkinson's Disease Rating Scale (UPDRS). Significant main effect at p<.01, post-test
was significantly less severe than pre-test and washout.
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Figure 3a - Main effect of the rate (sec/peg) for the remove phase of the grooved
pegboard for the affected side. Significant main effect at p<01, post-test and washout
were significantly faster than pre-test.
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CHAPTER 5
VERIFYING THE EFFECTIVENESS & REPLICABILITY OF THE SENSORY
ATTENTION FOCUSED EXERCISE INTERVENTION

ABSTRACT
There were two main aims of the current study. The first was to determine
whether a sensory attention focused exercise (PD SAFEX) intervention would result in
consistent symptomatic improvements across multiple administrations. The second was
to determine if the intervention could be replicated when administered by minimally
trained individuals in the community. The PD SAFEX intervention was administered six
times; four at the Movement Disorders Research and Rehabilitation Centre (MDRC); two
at an exercise facility in Oakville, ON (YMCA). Results demonstrated that regardless of
the administration group, similar percent change on symptomatic assessment (UPDRS),
indicating improved symptoms, was observed. Interestingly, the intervention at the
YMCA resulted in significantly greater symptom percent improvement than the MDRC
led PD SAFEX intervention. The results demonstrate that the PD SAFEX intervention
consistently provides symptomatic benefit and is likely to continue to display benefits if
globally implemented. The replicability of the findings from the PD SAFEX intervention
are particularly promising as rarely has an exercise intervention been shown to reliably
change the symptoms of a disease like Parkinson's. The minimal training and equipment
needed to implement the PD SAFEX intervention indicate that future directions should
consider widespread distribution of the PD SAFEX exercise descriptions and evaluate the
effect of the exercise in multiple settings and the home environment.
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INTRODUCTION
Currently, no scientifically based exercise recommendations exist for individuals
with Parkinson's disease (PD) (de Goede, Keus, Kwakkel, & Wagenaar, 2001; Deane et
al., 2002). One of the issues clouding the search for the optimal exercise strategy is the
difficulty of designing experiments that are capable of accurately comparing exercise
strategies. Often, similar exercise programs such as body-weight supported treadmill
training (BWSTT) (Miyai et al., 2000; Miyai et al., 2002), regular treadmill training
(Cakit, Saracoglu, Gene, Erdem, & Inan, 2007), and outdoor walking training (Lokk,
2000; Sunvisson, Lokk, Ericson, Winblad, & Ekman, 1997) cannot be compared due to
differing training lengths, and outcome measures used.
An additional challenge is that few rehabilitation studies have attempted to
demonstrate that the identified effectiveness of an exercise strategy is replicable over
multiple administrations. This is especially concerning when small sample sizes (N<10)
are used, which can leave findings susceptible to chance. For example, Miyai et al. found
conflicting results while examining body-weight supported treadmill training (BWSTT)
in two different samples often participants with PD (Miyai et al., 2000; Miyai et al.,
2002). The first project found that BWSTT resulted in improved PD symptoms measured
using the Unified Parkinson's Disease Rating Scale (UPDRS) (Miyai et al., 2000), while
the second project did not find a significant effect of training on PD symptoms (Miyai et
al., 2002). While no suggestion was provided to explain the discrepancy between the
symptomatic results, perhaps, the small samples (n=10 & 11) allowed day to day
fluctuations in PD symptoms to have undue influence on the results, suggesting that
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findings should be replicated with increasing sample sizes to effectively evaluate an
exercise intervention.
Conversely, del Olmo et al. found similar effects in two groups of individuals
with PD following four weeks of gait exercises that were paced with a metronome (del
Olmo, Arias, Furio, Pozo, & Cudeiro, 2006; del Olmo & Cudeiro, 2005). The first group
of 15 PD participants displayed a decreased coefficient of variation (a measure of
temporal variability of gait) following exercise (del Olmo & Cudeiro, 2005). The second
group of nine PD participants replicated these findings and also used positron emission
tomography (PET) to suggest that the coefficient of variation improvements were likely
the result of improved neural function (del Olmo et al., 2006). Clearly, replication of
exercise rehabilitation interventions is important to ensure any improvements are not due
to chance but the true result of a therapeutic intervention. To approve new drug
treatments for PD several studies to replicate the effectiveness are required, as witnessed
by the newest drug rasagaline, which underwent repeated evaluation before it could be
recommended and approved for use in North America (Pahwa et al., 2006; Rascol et al.,
2005). For an exercise to be accepted as an effective adjunct therapy for use in a clinical
population such as PD it should be subjected to the same rigorous testing as new
medications.
Of further importance is the feasibility for a PD exercise intervention to be
globally utilized. To be truly beneficial to the PD community the exercise intervention
must be easy to follow, simple and cost-effective to implement. Thus, while BWSTT or
resistance training may prove to be beneficial for individuals with PD, it may be
unrealistic to expect that all PD patients will be able to gain access to the specialized

116

equipment and appropriately trained experts to deliver such an intervention. As such, the
current study utilized minimal equipment (a standard office chair and latex Therabands®) and a group setting (less instructors required for more exercise participants) to
deliver an exercise intervention that was cost-effective and could be easily and effectively
administered to a large number of individuals with PD and that might be easily
transferred to the patient's home environment.
The current study had two main purposes. The first was to determine whether
improved PD symptoms following a sensory attention focused exercise (PD SAFEX)
intervention could be replicated across multiple administrations. The PD SAFEX program
was administered from September 2006 to December 2007, representing four twelve
week exercise sessions (fall 2006, winter, summer and fall 2007). In addition to the four
PD SAFEX sessions at the MDRC, the program was administered twice at a YMCA in
Oakville, ON from January to August 2007. As the PD SAFEX program was a new
intervention utilizing minimal equipment and a cost-effective group setting it was crucial
to determine if the exercise program could be effectively administered by members of the
community to assess the feasibility of global implementation of the program. Thus, the
second aim was to determine if the effect of the intervention could be replicated when
administered by the researchers (MDRC) or by minimally trained individuals in the
community (YMCA). It was hypothesized that PD SAFEX would result in consistent
symptomatic improvement across the administrations and that the MDRC and YMCA
would display similar improvements following exercise.
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METHODS
Participants
Thirty-nine participants (F-12, M-27, mean age=67.4, SD=9.8) were enrolled in
the current study from the patient database at the Movement Disorders Research and
Rehabilitation Centre (MDRC), Wilfrid Laurier University. The participants represent a
small portion of a large multi-site exercise rehabilitation study in PD. Participants'
completed the exercise intervention during the fall of 2006, or the winter, summer or fall
of 2007. As multiple exercise programs were investigated as part of the larger project and
participants could have been involved in successive programs, the current study included
those participants in their first exercise intervention who participated in all testing
sessions.

Exercise Intervention
Each participant was administered a sensory attention focused exercise (PD
SAFEX) intervention over a ten to twelve week period depending on the season of
administration (due to the respective holidays associated with the season). The exercise
intervention was run three times per week (Mon, Wed, and Fri) for approximately one
hour per session. The first 20-30 minutes was dedicated to PD SAFEX walking exercises
followed by 20-30 minutes of exercises using a standard office chair with latex Therabands® attached to the arms for resistance (for examples see a previously published
description (Sage & Almeida, In Press) and appendix A).
Two sites were used to determine the transferability of the exercise program to a
community setting. The exercise intervention at the first centre, the MDRC, was
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administered by one lead instructor and enough volunteers to maintain a 2:1 ratio of
participants to volunteers. The lead instructor had been educated on movement disorders,
specifically PD, and was familiar with the reasoning behind the design of the PD SAFEX
program. Similarly, the volunteers were senior undergraduate kinesiology students that
received training in the proper administration of the exercise program, and many of the
volunteers were enrolled in a movement disorders class. The volunteers' primary role
was to ensure participants completed each exercise properly, fix incorrect positioning and
remind participants of the sensory cues. The second site, the YMCA in Oakville Ontario,
had a team of 2-4 leaders who were personal trainers and group exercise leaders at the
exercise facility. The leaders observed two sessions of the PD SAFEX intervention at the
MDRC and received written instructions detailing each exercise, as well as a 1 hour
tutorial on the typical movement impairments they might expect to see with PD
participants. Open communication between the YMCA leaders and the MDRC was
available over the duration of the exercise intervention and the YMCA leaders did not
express any difficulty understanding the written description of the exercises. Participants
that required assistance to complete the exercises were encouraged to bring a family
member or personal assistant since volunteers or extra staff might not be unavailable at
this location.
The goal of the program was to have participants focus their attention on the
sensory, primarily proprioceptive, feedback received while completing the exercise
program. To force participants to focus and rely on proprioceptive feedback, vision was
dampened [as per (Rose, 2005)] or removed entirely as the exercise facility was darkened
and participants had their eyes closed for the second set of each exercise. The instructor
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also keyed participants to specific portions of each exercise and the sensory feedback
received during proper completion of the exercise. Each week the exercise intervention
became progressively more challenging as new exercises were added or existing
exercises were modified.

Evaluation
A single evaluator blinded to group assignment assessed each participant before
the exercise program began (pre-test) and again following the exercise program (posttest). Blinding was achieved by testing participants from multiple exercise programs and
non-exercise control participants in a random order on the same day with participants
instructed not to reveal their group assignment. The primary outcome measure was an
assessment of PD motor symptoms using the Unified Parkinson's Disease Rating Scale
(UPDRS). The UPDRS provides a rating of PD symptom severity as each motor
symptom was rated using a scale of zero to four with zero being an absence of symptoms
and four representing the most severe symptoms. Thus, a higher UPDRS indicated more
severe PD symptoms; the maximum score was 108.
Statistical analysis was completed using Statistica computer software, following
'intention to treat' principles, and an alpha level set at .05. Any significant findings in
analysis of variance were followed up using Tukey's post-hoc criteria. The first analysis
was a time (pre-test vs post-test) by group (MDRC: fall 2006 vs winter 2007 vs summer
2007 vs fall 2007 vs YMCA: winter 2007 vs summer 2007) analysis of variance. As the
groups were small and pre-test disease severity was not controlled, a percent change was
calculated to standardize the improvements regardless of pre-test disease severity. The
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percent change was calculated as (pre-test - post-test)/pre-test x 100% such that a
positive percent change indicated an improvement following exercise. A one-way
ANOVA comparing the percent change for the six exercise administrations was analyzed.
The second analysis collapsed the exercise groups based on the site of
administration to determine if a difference existed between the MDRC and YMCA. A
group (MDRC vs YMCA) by time (pre-test vs post-test) ANOVA and an independent ttest of the UPDRS percent change were used to compare the groups.
Finally, an analysis of participants who received the PD SAFEX intervention in
two consecutive 12-week exercise sessions (separated by a six week non-exercise period)
was performed to assess the effect of a multiple administrations over a longer period. As
only five participants had completed the PD SAFEX program in successive time periods
this analysis was preliminary and exploratory. The scores at pre-test and post-test were
compared for both the first and second administration of PD SAFEX using a repeated
measures ANOVA. Additionally, a dependent t-test was employed to compare the
percent change from the first and second administrations of the PD SAFEX program.
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RESULTS
Exercise participants at the MDRC and YMCA had comparable ages and disease
severity levels. The YMCA group had a smaller mean number of years since diagnosis
(mean=2.4) of PD than the MDRC group (mean=4.8). Table 1 provides a breakdown of
baseline demographics for the two locations.

Group Comparisons
The group by pre-test vs post-test UPDRS score ANOVA revealed a main effect
of time (F(l,33) = 56.89, p<.001) indicating that post-test disease severity scores were
significantly lower than pre-test scores. No interaction was identified between the groups
(F(5,33) = 1.67, p<.169) as all groups improved at post-test compared to pre-test. The
percent change ANOVA was also non-significant (F(5,33) = 1.79, p<.141) (figure 1). See
table 2 for a full breakdown of results for each group.
The MDRC and YMCA comparisons yielded a main effect of time (F(l,37) =
67.66, p<.001) indicating that disease severity scores were lower at post-test compared to
pre-test. No interaction effect was identified (F(l,37) = 1.49, p<.23) (figure 2). The
percent change independent t-test revealed a significant difference between the groups
(t(37) = 2.11, p<.042), where the YMCA (mean = 39.14, SD = 15.4) had a significantly
larger percent improvement than MDRC (mean = 25.06, SD = 19.9) (figure 3).
The first versus second administration of the PD SAFEX program had a trend
towards a main effect of time (F(l,4) = 6.42, p<.064), with no significant interactions
identified. Additionally, no difference was found on the percent improvement as the first
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(mean = 21.1) and second (mean = 22.8) administrations had similar responses to the PD
SAFEX program.

DISCUSSION
The aims of the current study were to determine whether the effectiveness of PD
SAFEX intervention could be replicated consistently across multiple administrations of
this novel therapeutic intervention, and specifically whether effectiveness could be
maintained when delivered in the community (YMCA). Consistent results were observed
across the four administrations of the PD SAFEX intervention at the MDRC and the two
administrations at the YMCA. Interestingly, the YMCA run program resulted in a larger
percent improvement than the MDRC run program.
A larger percent improvement at the YMCA compared to the MDRC is especially
interesting because the exercise leaders at the MDRC had more training in movement
disorders and had more volunteer assistants to ensure participants completed the
exercises properly. This finding suggests that with minimal training of exercise leaders
the PD SAFEx intervention could be easily implemented on a large scale and participants
could expect to receive identical benefits as the samples evaluated in the current study.
Another strength of the current study was the use of a disease specific measure (UPDRS),
as this allows the PD specific effect of the exercise to be evaluated. Further, it has been
suggested that symptoms of disease (as measured with the UPDRS) are not as easily
influenced by exercise as specific mobility measures such as step length (de Goede et al.,
2001). Thus, the improvement in PD symptoms replicated in multiple administrations of
the PD SAFEX intervention and across multiple sites suggests with reasonable external
validity that it is feasible to implement the intervention globally.
The design of the larger research project into the effect of exercise on PD at the
MDRC meant that the groups involved in their first administration of the PD SAFEX
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intervention varied in size and were fairly small. The small groups were a limitation of
the current study; however, all groups did witness an improvement in UPDRS score
following exercise. The smallest group of only three participants in the winter of 2007 at
the MDRC witnessed the smallest percent change of only 7.2% whereas the largest group
of twelve participants in the fall of 2006 at the MDRC witnessed a substantial percent
change of 24.7%. Further, the sample of twelve participants is larger than a number of
commonly referenced PD exercise rehabilitation trials (del Olmo et al., 2006; Marchese,
Diverio, Zucchi, Lentino, & Abbruzzese, 2000; Miyai et al., 2000; Miyai et al., 2002). As
such, the small sample sizes, while not as large as desired, were sufficient as the results
were observed consistently across the groups.
Only five participants had completed the PD SAFEX intervention during
consecutive exercise sessions (with a six week non-exercise period in between) as
participants were randomly assigned to the different exercise programs as part of the
larger research project. Thus, the comparison of the effect of the first and second
administrations of the PD SAFEX intervention should only be considered preliminary.
Nevertheless, during both the first and second exercise sessions the group improved their
UPDRS scores by 21.1 and 22.8% respectively. It may have been expected that
participants would receive an additional benefit of the PD SAFEX intervention during the
second administration as they did not need to learn each exercise. This was not observed
in the current sample; however, when the sample size is increased a more adequate
comparison can be made about the effects of the PD SAFEX intervention over a longer
period of time.
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Rarely has it been demonstrated that an exercise intervention can reliably change
the symptoms of a disease like Parkinson's. The results of the current study demonstrate
that PD symptomatic improvements are reproducible with the use of the PD SAFEX
intervention, thus providing evidence that suggests that exercise focused on sensory
feedback is beneficial and the results were not simply due to chance. Additionally, the PD
SAFEX program requires minimal equipment and training for exercise leaders, as
supported by the observed improvements in the YMCA groups, which is ideal to
implement the exercise intervention on a wider scale. One limitation of the current study
was a lack of quality control to ensure that the YMCA exercise leaders were properly
administering the PD SAFEX intervention. While the YMCA leaders may not have
properly instructed some of the minor details of the program, they certainly ensured
participants exercised with their eyes closed. Having the eyes closed while exercising
was the most important aspect of the PD SAFEX program as it forces participants to rely
on proprioceptive and not visual feedback. The results of the current study suggest that
this aim can be easily implemented by community exercise leaders, although future work
should evaluate the exercise leaders to ensure consistent instructions are provided to
participants.
Future research should distribute the exercise intervention across multiple sites in
Canada to determine the effectiveness of the PD SAFEX intervention based on a
simplified manual providing a description of the program to the exercise leaders. An
additional important direction would be to evaluate the effectiveness of the intervention
when completed in the home environment to increase the number of individuals able to
benefit from the novel PD SAFEX intervention.
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Table 1 - Mean (±standard deviation) of participant demographics at baseline for the
MDRC and YMCA.

Group

Gender

Age

Years Since
Diagnosis

UPDRS

68.3(10.6)
4.8 (4.3)
28.2(10.3)
MDRC
F-9.M-19
65.3
(7.5)
2.4(1.4)
25.3 (9.6)
YMCA
F-3, M-8
Total
F-12, M-27 67.4 (9.8)
27.4(10.0)
4.1 (3.9)
UPDRS, Unified Parkinson's disease rating scale; MDRC, Movement Disorders
Research and Rehabilitation Centre.
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Table 2 - Mean (±standard deviation) of UPDRS scores and percent change for the six
groups. Percent change calculated using: (pre-test - post-test)/pre-test x 100%
Group
n
Percent Change
Pre-test
Post-test
12
MDRCI
21.0(10.5)
24.7 (20.9)
27.4(10.8)
3
MDRCII
27.5 (8.5)
25.0 (5.4)
7.2(13.1)
MDRC III
5
20.2 (4.1)
27.4 (28.0)
14.7(6.1)
MDRC IV
8
30.8(12.8)
34.6 (9.9)
20.4(11.0)
YMCAI
4
13.0(5.4)
29.5 (12.3)
32.2(14.5)
YMCAII
7
19.5 (8.9)
43.1 (15.5)
23.0(7.8)
UPDRS, Unified Parkinson's disease rating scale; MDRC, Movement Disorders
Research and Rehabilitation Centre

MDRCI
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MDRC III

MDRCIV

YMCAI

YMCAII

Figure 1 - UPDRS percent change following exercise in the six groups. Note that no
significant difference was found between the groups.
UPDRS, Unified Parkinson's disease Rating Scale; MDRC, Movement Disorders
Research and Rehabilitation Centre
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Figure 2 - UPDRS score changes following exercise for the two exercise locations. Note
that the main effect of time (pre-test vs post-test) was significant (p<.001) but is not
marked.
UPDRS, Unified Parkinson's disease Rating Scale; MDRC, Movement Disorder
Research and Rehabilitation Centre
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CHAPTER 6

GENERAL DISCUSSION
The overall objective of the current thesis was to compare various exercise
interventions to determine the most advantageous strategy for individuals with
Parkinson's disease (PD). To achieve this aim chapter two investigated the ability of
objective outcome measures to reflect symptomatic assessment using the Unified
Parkinson's Disease Rating Scale (UPDRS). Chapter three compared four exercise
programs, representing a spectrum of traditional exercise strategies and a sensory
feedback based strategy, with a non-exercise control group to determine which exercise
strategies had the greatest beneficial effect on PD motor symptoms. Chapter four
investigated the role of increased focus on sensory (specifically proprioceptive) feedback
in an exercise program through a comparison between a sensory attention focused
exercise (PD SAFEX) program and an identical program differing only on the absence of
focus on sensory feedback. Finally, chapter five assessed the ability of the PD SAFEX
program to be administered in the community by comparing multiple administrations of
the PD SAFEX program run by the researcher and community instructors who received
minimal training in the proper administration of the exercises.

Objective measures that reflect PD symptoms
While symptom management would be the primary goal for any therapeutic
intervention, minimal investigation has been done to determine what objective measures
are best able to reflect the classical symptoms of PD. Chapter two tackled this important
question by assessing which objective measures were the best predictors of PD symptoms

135

(measured using the Unified Parkinson's Disease Rating Scale (UPDRS)). Additionally,
the ability of objective measures to reflect symptomatic changes resulting from exercise
was also evaluated. The results suggested that the grooved pegboard (GP), specifically
the place phase, was the best measure to predict symptomatic assessment. Interestingly,
none of the objective measures had a significant relationship with the symptom changes
(measured as subsets of the UPDRS), they were hypothesized to be evaluating.
Unfortunately, the current thesis only identified the grooved pegboard (GP) as an
effective predictor of PD symptoms. Even then, the best predictor, the GP place phase
only accounted for less than 30% of the variability in UPDRS score, leaving over 70%
unaccounted for. Thus, the search for effective objective measures has just begun.
Functional measures such as the timed-up-and-go should continue to be investigated as
they may be evaluating symptomatic deficits identified through the UPDRS.
Additionally, functional measures, although not seen to be reflective of symptomatic
changes in the current thesis, may reveal the ability of an individual to function in their
home environment. Overall, the results of the current thesis suggest that other objective
measures should be investigated for their ability to reflect symptomatic assessment.
While numerous potentially beneficial objective measures exist, a few intriguing
directions to build on the current study are movement variability and muscle activation
patterns. Movement variability especially during gait has been suggested to be attributed
to abnormal internal cues being sent from the basal ganglia to guide sequential
movements (del Olmo & Cudeiro, 2005). One estimate of movement variability is the
coefficient of variation (standard deviation/mean) x 100), which standardizes variability
to the mean (Almeida, Frank, Roy, Patla, & Jog, 2007). Interestingly, del Olmo et al.
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have found significant improvements in the coefficient of variation for step length and
finger tapping following gait exercises rhythmically paced by a metronome (del Olmo,
Arias, Furio, Pozo, & Cudeiro, 2006; del Olmo & Cudeiro, 2005). Similarly, muscle
activation patterns may be hindered due to the disrupted basal ganglia in PD. Thaut et al.
observed improvements in muscle activation of the lower leg towards a more normalized
activation pattern following gait exercises paced externally by a metronome (Thaut et al.,
1996). Since movement variability and muscle activation have been suggested to be
reflective of the functioning level of the basal ganglia measures of these movement
aspects may also be reflective of PD symptoms. A logical future direction would be to
assess the ability of these and other novel measures to reflect symptomatic assessment of
PD.
While the current thesis only identified the GP as a significant predictor of
symptomatic assessment, future exploration in this area is necessary. Determining which
objective measures are most reflective of symptomatic assessment in PD would greatly
benefit researchers evaluating exercise techniques. Outcome measures could be
standardized for future trials and previous literature could be effectively scrutinized to
determine its symptomatic effect. Currently, however, symptomatic measures such as the
UPDRS should accompany objective measures to ensure changes observed are disease
relevant and not simply general musculoskeletal or cardiovascular benefits that any
individual would expect to receive from the exercise.
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Which exercise technique is best?
Chapter three aimed to determine the most beneficial exercise strategy for
individuals with PD by improving on previous shortfalls including inconsistent length of
exercise interventions, inconsistent use of PD symptomatic measures, absence of a nonexercise follow-up assessment and lack of a placebo/control group. Three exercise
programs based on traditional exercise strategies including aquatic exercise, aerobic
training and strength training were compared to a novel exercise strategy, sensory
attention focused exercise (PD SAFEX), and a non-exercise control group. All participants
exercised three times a week for twelve weeks and were symptomatically assessed using
the Unified Parkinson's Disease Rating Scale (UPDRS). Overall, the strength training
and PD SAFEX programs were seen to have the greatest symptomatic improvement
following exercise.
While the PD symptomatic evaluation using the UPDRS provided an adequate
comparison between the exercise strategies a detailed evaluation between the strength
training and PD SAFEX programs is warranted to evaluate if the symptomatic
improvements witnessed are the result of improved neurological functioning or
musculoskeletal fitness. The UPDRS is the current gold standard of PD symptom
assessment; however a number of items may be unduly influenced by strength gains. For
example, items such as sit-to-stand, posture and postural stability may be improved due
to musculoskeletal strengthening. The PD SAFEx program was not focused on aerobic or
strength gains; rather the focus was improved body awareness and coordination. Thus,
the improved symptoms in the PD S AFEX group may be due to improved movement
control (neurological functioning) while the improvements in the strength training group
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may be influenced by improved musculoskeletal strength. The current thesis, however,
cannot adequately evaluate whether the benefits from the two exercise programs are the
result of improved neurological function or increased muscle strength, and future work
should include an in depth analysis of the two programs to address this important area.
A number of important factors were controlled in the current evaluation of
exercise techniques such as identical exercise lengths, PD symptomatic assessment, and
the comparison with a non-exercise control group. Thus, the methodological quality of
the current thesis suggests that strength training and PD SAFEX have the greatest
symptomatic benefit for individuals with PD.

The role of increased focus on sensory feedback in exercise
The influence of increased focus on sensory feedback (specifically
proprioception) in an exercise setting has never been evaluated in PD. Thus, a
comparison of two programs that differed only in the presence or absence of increased
sensory attention (permitting the isolation of this single variable) was undertaken. The
results of this study were strengthened by the fact that both programs were administered
by the same individual in a single facility. Thus, the only difference between the
programs was the focus on sensory feedback. Interestingly, both programs benefited on a
number of measures (timed-up-and-go, grooved pegboard remove phase, and step length)
but only the sensory attention focused exercise (PD SAFEX) program had improved PD
symptoms displaying the additive benefit of increased focus of attention on sensory
feedback.

139

The difference between the exercise programs was only evident on the
symptomatic assessment of PD symptoms. However, this is of increased importance as
the goal of any exercise intervention in PD should be to improve symptoms.
Additionally, this points to the importance of including symptomatic assessment in
exercise rehabilitation trials to ensure changes are disease relevant. Without a
symptomatic evaluation the current study may have concluded that increased sensory
feedback does not provide additional benefit. This suggests that previous exercise trials in
PD without a symptomatic evaluation do not provide a complete picture and may be
concluding success based on general musculoskeletal, cardio respiratory or mobility
benefits rather than PD relevant symptomatic improvement. Any therapeutic intervention
(drug, exercise or alternative therapy) should combine symptom measures and also other
objective functional outcome measures to evaluate the functional and symptomatic
benefit of the therapy in question.
The current results do suggest that focused attention on sensory feedback is an
effective addition to PD exercise rehabilitation. Achieving increased focus on sensory
feedback was relatively simple to integrate as this was achieved in the current program by
having participants close their eyes, thus the potential application to other settings would
be a logical area to explore.

Replicability of the PD SAFEx intervention
Chapter five attempted to verify whether the effectiveness of the PD SAFEX
intervention could be replicated across multiple administrations. This was an important
consideration, since exercise interventions are rarely scrutinized to the same degree that
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pharmaceuticals are before treatments are approved. For example, Miyai et al. assessed
body-weight supported treadmill training in two separate groups and while the first group
revealed symptomatic benefit, the second did not (Miyai et al, 2000; Miyai et al, 2002).
The results of the current study revealed that the symptomatic improvements were
replicable as improved PD symptoms were found following four administrations of the
PD SAFEX intervention at the Movement Disorders Research and Rehabilitation Centre
(MDRC) and two administrations of the PD SAFEX program at an exercise facility in the
community (YMCA).
Of further interest was the ability of the PD SAFEX program to be implemented in
a community setting with minimal training of exercise leaders. Interestingly, the PD
SAFEX program implemented by the researcher (MDRC) had a significantly lower
percent improvement following exercise than the PD SAFEX program led by individuals
in the community (YMCA). This finding was unexpected as it was thought that
knowledge of the underlying neurological deficits in PD that were the focused in the PD
SAFEX program would lead to more accurate exercise descriptions. While the sample size
(n = 11) of the YMCA group was fairly small, the results point to the ease of
administration of the PD SAFEX program and the suitability of the exercise intervention
for the general PD population. The main goal of the PD SAFEX program was to increase
focus on sensory (specifically proprioceptive) feedback and was mainly achieved by
having participants complete the exercises with their eyes closed. Thus, while the YMCA
exercise leaders may not have achieved all the smaller aims of the PD SAFEX program,
they would have ensured participants kept their eyes closed and this may be enough to
increase attention on sensory feedback.
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The external validity of the PD SAFEX program is excellent as the symptomatic
results were found over multiple administrations and under different exercise leaders. As
the PD SAFEX program was effectively administered by individuals receiving little
training a logical progression would be to evaluate the PD SAFEX program in the home
environment. As mobility becomes more difficult as disease severity increases the
simplicity of the PD SAFEX program may be ideal to apply in an individual's home.

Conclusion
Improving upon numerous shortfalls in previous research such as inconsistent use
of symptomatic measures, differing lengths of intervention, lack of an adequate control
group and absence of assessment following a non-exercise washout period, the most
effective exercise rehabilitation interventions revealed by the current thesis were strength
training and sensory attention focused exercise (PD SAFEX). Further evaluation of the PD
SAFEX program revealed that increased focus on sensory feedback was easy to
implement and reliably provided symptomatic improvements. Thus, increased focus on
sensory feedback appears to be a simple, effective strategy that improves PD symptoms
and likely leads to improved neurological functioning of the basal ganglia, the central
deficit of PD. Future research should continue to evaluate the long term delivery of PD
SAFEX; increase the sample size; continue to search for better objective measures; and
evaluate PD SAFEX in the home environment after providing minimal instruction.
Additionally, future work should attempt to combine benefits gained from aerobic
training, strength training and PD SAFEX since increased strength and cardiovascular
health may also be important to combat secondary deficits associated with PD.
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Future Recommendations
The PD S AFEX and strength training programs had the greatest positive influence
on PD symptoms. Specifically, the PD SAFEX program requires minimal equipment and
appears to be easy to implement in the community environment. However, it will be
important to address several important areas to confirm the effectiveness and delivery of
this program.
•

Assess effects of exercise across wide range of disease severities.

•

Combine the exercise interventions such as strength training and PD SAFEX to
maximize benefits.

•

Detailed comparison of strength training and PD S AFEX to determine if
symptomatic improvements are the result of neural or musculoskeletal changes.

•

Increase sample size to address loss of participants, especially at washout testing.

•

Determine if individuals who receive a greater benefit of exercise also have a
greater lasting benefit (compared to individuals who do not receive a large benefit
of exercise).

•

Administer the PD SAFEX intervention at numerous sites and evaluate the
instructors to ensure exercises are identical at all sites.

•

Investigate longer exercise periods such as 24 weeks or one year, especially for
the PD SAFEX program. Compare longer administrations of PD SAFEX with nonexercise control participants to compare progression of PD symptoms.

•

Evaluate the PD SAFEX program in the home environment with minimal
instruction to determine its effectiveness for individuals with limited mobility.
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APPENDIX A
DESCRIPTION OF THE SENSORY ATTENTION FOCUSED EXERCISE (PD
SAFEX) INTERVENTION
From:
Sage, M.D., & Almeida, Q.J. (In Press). Symptom and gait changes after sensory
attention focused exercise vs aerobic training in Parkinson's. Mov Disord.
Description of Sensory Attention Focused Exercise (PD SAFEX) program
The goal of the PD SAFEX program was to focus patient's attention on sensory feedback
during movement (specifically proprioceptive feedback). This was accomplished using
exercises that would challenge coordination, body awareness and balance while cueing
participants' to specific sensory feedback from each exercise. Exercises were done in a
group setting, 1 instructor and 6-8 student volunteers for approximately 1 hour. Exercise
sessions were completed with lights dimmed and eyes closed for most sets of exercise.
The exercises became progressively more difficult each week by increasing the
coordination demands on the participants.
Gait Exercises (20-30 min)
A 37.5 meter hallway at the Movement Disorders Research & Rehabilitation Centre,
Wilfrid Laurier University) was traversed twice to make a 75 meter circuit used for many
of the exercises. Student volunteers were placed along the middle of the hallway to
reinforce instructions, ensure participants completed exercises properly and remind
participants of the specific sensory feedback to focus on for each exercise.
General instructions for all gait exercises:
1. Go Slowly - Participants walked at a slow pace to ensure they completed each
exercise properly and this allowed participants time to interpret the proper sensory
feedback cues (without any specific focus on improving aerobic capacity).
2. Keep eyes closed - The first time a new exercise was introduced, participants
completed the circuit with eyes open. In subsequent repetitions, participants were
instructed to keep eyes closed for longer periods of time, i.e. keep eyes closed for
two steps, open for one. After 2 rounds of the exercise participants kept eyes
closed for the entire circuit.
Specific examples from PD SAFEX program
EXERCISE

Weekl

Week 6

Opposite arm and leg move together
with aim of bringing the hand up to the
cheek, while opposite knee was raised
up until thigh was parallel to ground.
E.g. right hand comes up to ear and left
knee is raised.
Holding shirt at the shoulders with
upright correct posture, bring the knee

SENSORY ATTENTION
FOCUS
i) Limb coordination pattern is
same as during gait
ii) Hand and cheek contact sends
tactile feedback
iii) Upright posture reinforced
i) Twist challenges balance and
coordination
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Week 12

up and across the body while twisting
the torso to have the elbow and knee
contact; do not bend at the waist to
bring the elbow down to the knee.
Alternate between 10 steps heel-toe
walking ensuring the heel and toe touch
every step. Then 5 'Stomp' Lunges:
step forward as large as possible, and
stomp the front foot into the ground by
landing on the heel and 'slapping' toes
on the floor). Bring rear knee down to
contact the floor and then back up.

ii) Knee and elbow contact
provides feedback to confirm
limb position
iii) Upright posture reinforced
i) Heel-toe contact provides
tactile feedback to confirm feet
position
ii) 'Stomp' increases sensory
feedback sent to the CNS
iii) As knee touches floor,
participants confirm they are
completing exercise properly

Sensory Attention (Chair/Room) Exercises (20-30 min.)
Equipment used for this portion of the exercises included a standard office chair with arm
rests and two latex Thera-bands®. The aim was not strength or aerobic training and the
Thera-bands® were used to provide minimal resistance when completing certain upper
limb exercises.
General Instructions for Exercises:
1. Sensory Reminders - Instructor's description of exercises focused on key
portions for participants to focus on. Volunteers also reminded participants
what to focus on while completing exercises.
2. Lights Off, eyes closed - Lights were turned off in exercise room and second
set of each exercise was done with eyes closed. This forced participants to rely
on prioproceptive and not visual information to ensure limbs were in the
correct position.
Specific examples from PD SAFEX program
EXERCISE
Both hands on the back chair legs, back
against chair and chest pointing out. Slide
right hand down right chair leg, while
sliding left hand up left chair leg; hold,
then switch sides and repeat.
Weekl
Alternating bicep curls in continuous
motion. E.g. as right arm curls, left arm
simultaneously relaxes.

Week 6

Standing toe circles using the back of the
chair for support. Trace a large circle on
the floor with the big toe. Supporting leg
bends at the knee to allow a larger circle
to be traced.

SENSORY ATTENTION
FOCUS
i) Hands on chair legs, and
stretch through torso
ii) 2nd set confirm that stretch
is the same as 1st, using only
the above sensory feedback
iii) Upright posture reinforced
i) Hand & shoulder contact,
providing sensory feedback to
indicate end of curl
ii) Opposite motion of upper
limbs challenges coordination
i) Tactile feedback from the
toe tracing circle
ii) Balance challenge for
supporting leg
iii) Upright posture reinforced
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Week 12

Pretend arms are the arms of a clock and
move to time chosen by instructor while
holding Thera-bands® with palms facing
the floor.
Imagine holding a basketball with both
hands. While inhaling, roll ball in front,
bending at the waist. From here, move the
hands to encircle the left side of the ball.
While exhaling, roll ball to the right.
Reach around the far side of the ball and,
while inhaling, roll the ball into the chest.
Exhale while holding ball at chest.
Repeat, rolling the ball to the left.

i) Difficult coordination
ii) Participants ensure proper
limb position based on
proprioceptive feedback
i) Difficult coordination of
limbs, hands, torso &
breathing
ii) Utilize proprioceptive
feedback to position hand
correctly to "rolf ball in
desired direction
iii) Upright posture reinforced

